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were synthesized by soap free emulsion polymerization. Bovine serum albumin was then immobilized 
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fluorescence spectra, ITC measurements and unfolding studies using urea of immobilized protein were 
carried out to analyze conformational changes in the protein. 
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adsorption on the surface of a polymer nanoparticle. 
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Abstract 
Proteins are essential parts of organisms and participate in virtually every process within 
cells. Being able to control them, deliver them to specific locations or give them desired 
functionalities and properties pave the way to numerous applications, including use as 
biosensors, within biocatalysis and biomedical devices. Thus, protein monitoring is 
extremely relevant and one of the most important challenges in biotechnology. One way to 
protein monitoring could be related to understanding and controlling their tertiary structure. It 
is known that the properties and functions of proteins are determined by their conformation. 
Therefore being able to induce conformational changes in proteins may be a possible way 
to control them. 
In the present study, a series of experiments with Bovine serum albumin (BSA) were 
performed, analyzed and described to understand the adsorption, unfolding behaviour and 
conformational changes in tertiary structure of this protein when it was attached and spread 
on the surface of different types of polymer nanoparticles. BSA was selected since it is well-
studied protein, the most abundant protein in plasma and one of the most used model 
protein. Three kinds of negatively charged monodisperse polymer nanoparticles were 
elaborated by soap free emulsion polymerization: two different size polymer nanoparticles 
with epoxy groups and one type of polymer nanoparticles without epoxy groups. Finally, size 
and zeta potential measurements of corresponding BSA-polymer nanoparticle constructs, 
fluorescence spectroscopy, isothermal titration calorimetry (ITC) and unfolding studies with 
urea were carried out to study BSA conformational isomerisation in immobilized polymer 
nanoparticle systems. All experiments were done at three different pH conditions; 3.8, 7.4 
and 9, corresponding to conditions below and above the isoelectric point (pI) of BSA. 
BSA immobilization and degree of unfolding was found to be strongly affected by pH and 
matching of the global protein and polymer nanoparticle charges. The results suggested 
that polymer nanoparticles with epoxy groups offered covalent binding with stronger 
attachment and larger conformational isomerisation than polymer nanoparticles without 
epoxy groups. These changes occurred to the largest degree at pH 7.4. This may be due to 
a high number of epoxy groups conjugated with amino groups of the protein. At pH 3.8 it 
seemed that the attachment of BSA was highest but without relevant structural alterations 
while at pH 9 it was in an intermediate level of adsorption and structural changes. Finally, 
there were no appreciable discrepancies between different size polymer nanoparticles. 
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1. Introduction 
The principles of physics, as far as I can see, do not speak against the possibility of 
manoeuvrings things atom by atom. It is not attempt the violate any laws; It is something, in 
principle, that can be done; but in practice, it has not been done because we are too big. 
Richard Feynman, 1959. 
Nanotechnology can be understood as the capacity to control and manipulation of matter at 
an atomic scale [1]. The idea of nanotechnology was first presented by Richard Feynman in 
1959 in a lecture “There is Plenty Room at the Bottom” [2] and nowadays molecular 
nanotechnology lead us to creating molecules individually atom by atom. Some scientists 
have speculated that the fabrication of a single working assembler, so-called bottom-up 
approach, would explode to fill every need and utterly changes our way of live [3]. Bottom-
up fabrication may in the future offer rather important advantages in comparison than the 
top-down category current used. Fabrication of nanostructures fall without exception into 
this focusing as the construction principle mimics biological systems by using the order 
factors that are innate in the system [4]. A precondition for nanostructure preparation by 
self-assembly way is the availability of sufficiently stable building blocks, which have to be 
well characterized and uniform with respect to size and shape. They should ideally also be 
chemically versatile enough to undergo a range of reaction, allowing them to fulfil various 
structural and/or functional roles within the final system. The capacity of three-dimensional 
assembly, simplicity in the experimental atomic scale and the potential for economical and 
environmentally friendly mass assembly are some of the prospective points in 
nanotechnology. Unfortunately, assemblers based on mechanosynthesis currently remain in 
the beginning, and there are also some mentions of potentially huge problems with these 
assemblers, sometimes referring to the catastrophic end result as the Grey goo problem1. 
                                               
 
 
1 The term was first used by nanotechnology pioneer Eric Drexler in his book Nanotechnology: the rise 
of the machines created (Engines of Creation, 1986). It refers to a hypothetical end of the world that 
involves molecular nanotechnology in which out-of-control self-replicating robots consume all matter 
on Earth while building more of themselves.  
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Another new concept that in the last half century has acquired an important role in the new 
development science is biotechnology introducing for Karl Ereki in 1919 [5]. Biotechnology 
uses the ready-made assemblers available in living cells to build thousands of custom-
designed molecules to atomic specifications, including the construct of new assemblers [6]. 
This has lead to innumerable applications, including commercial production of drugs, 
elegant methods for diagnosing and curing infections as genetic diseases, and engineering 
of organisms for specialized tasks such bioremediation and disease resistance. However, 
the biological functioning is based on cells and their components, which are to be found in 
an atomic scale size. For this reason biotechnology and nanotechnology are two branch of 
science that need inevitably advance in parallel. In this sense the term of bionanotechnology 
is a key factor [7][8][9]. Today, individual bionanomachines are being designed and created 
to perform specific nanoscale tasks, such as the targeting of cancer cell or the solution of a 
simple computational task. As bionanotechnology matures, it is possible to redesign the 
bimolecular machinery of the cell to perform large-scale tasks for human health and 
technology.            
Protein is the most versatile of natural bimolecules and one of the most important 
macromolecules in bionanotechnology [8]. Powerful methods for creating custom protein 
are available but the major current limitation is basic knowledge. Among other interesting 
qualities, it is known that changes in protein conformation, interpreted in general terms, 
regulate their function, such as specific interaction with other molecules, catalytic activity, 
and signal transduction [10]-[13]. We need to understand and be able to predict the 
process by which proteins fold into stable, globular structures and how its conformational 
changes are related to their functionality. Protein conformation and the folding and unfolding 
mechanisms could lead us to monitoring protein functions and use this knowledge to find 
out the cause of some diseases and diseases cure. Alzheimer’s, Parkinson’s, Huntington’s 
are related to protein misfolding and are some of many medical areas which in proteins play 
an important role. It is well known that conformational changes can be induced by protein 
association to a surface, whether the surface is a membrane or other entity such as a 
nanoparticle [14]-[18]. Nowadays the use of nanoparticles paves the way to understand 
chemical and physical governing proteins factors [19]. Nanoparticles small size allows 
interacting with proteins (Figure 1.1) [20]-[23]. The set of themes deals with how reduced 
dimensionality of proteins by adsorption to a surface of nanoparticles can be use as folding 
templates for polypeptides [24].  
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Figure 1.1. Glimpsing how peptides self-assemble on a gold nanoparticle by unfolding mechanism. Adapted from 
<http://www.rsc.org/chemistryworld/News/2008/August/20080801.asp> [22/10/10]. 
A good example that shows the importance of the conformation of proteins and how 
changes in their structure affect their functionality is the HAMLET protein (human α-
lactalbumin made lethal to tumour cells). HAMLET is a complex of human apo α-
lactalbumin, specific folding variant, and oleic acid (Figure 1.2) which it is known to induce 
apoptosis in cancer cells and immature cells, but not in mature healthy cells [25][26]. The 
presence of oleic acid during protein folding kept the protein in stable partially unfolded 
active form. Alpha-Lactalbumins (-La) are structurally conserved among species 
suggesting that HAMLET-like complexes might be formed from other species variants of -
La [27][28]. However HAMLET and its variants have limited availability and complex growth 
and separation process, but if native -La or other analogous proteins could achieve the 
same apoptosis properties when spread on the surface of a nanoparticle, a new efficient 
and cheap cancer medicine is possible [29]-[31].  
 
Figure 1.2. HAMLET protein. Adapted from <http://www.mig.lu.se/svanborg.hamlet.html> [26/10/10]. 
Bovine serum albumin (BSA) [32][33] has similar features to HAMLET and α-La, such as pI, 
but it is easier to obtain and cheaper, even though it hasn’t the capacity to induce apoptosis 
to tumoral cells. BSA is a good protein model because is abundant and different proves has 
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been successfully used such as ANS, intrinsic fluorescence or probes covalently bound to 
study it [34 and bibliography].   
The objective of the project is to develop a stable support for BSA immobilization, as well as 
evaluate conformational changes of immobilized proteins in buffered aqueous media at 
different pH. Herein, two kinds of negatively charged monodisperse polymer nanoparticles, 
with and without epoxy surface groups, at different sizes were synthesized by soap free 
emulsion polymerization. BSA was then immobilized at different protein concentrations and 
pH values. Finally, zeta potential of protein-polymer nanoparticle constructs at various pH, 
fluorescence spectra, isothermal titration calorimetry (ITC) measurements of immobilized 
protein (section 3 Characterization techniques) and unfolding urea studies were performed 
to analyze conformation changes of BSA protein. 
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2. Adsorption of proteins on the surface of 
polymer nanoparticles 
The present section aims to provide the necessary information to understand protein-
nanoparticle interactions and thus to give a coherent explanation for the results obtained 
during the project BSA-polymer nanoparticle constructs. The study of proteins and the use 
of nanoparticles is not a coincidence; both have a specific molecular structure and 
determined features that allowing them to be compatible with each other. Nanoparticles can 
induce conformational change to proteins which is really important as already been 
mentioned. Therefore it is first necessary to know the properties and behaviour of these two 
molecules.  
2.1. Polymer nanoparticles  
A nanoparticle is defined as a small body with a definite mass having one or more 
dimensions the order of some hundred nanometers or less that behaves as a whole unit in 
terms of its transport and properties1. Nanoparticles may or may not exhibit size-related 
properties that differ significantly from those observed in fine particles or bulk materials [19]. 
The use of nanoparticles has gained popularity in recent years, and the numbers of 
applications is increasing dramatically as science progress, especially in medicine [35][36]. 
Despite the need to understand the response of biological systems to these particles, for the 
moment there are few overall conceptual frameworks and remains unclear the mechanisms 
that govern biological processes at nanoscale [37]. Nanoparticles, when entering the body 
become coated with proteins, which means that there exist some interactive capability and 
this may have several effects on the proteins. [20]-[24] [38]-[40]. The proteins might 
become partially unfolded upon adsorption, producing conformational alterations with 
subsequent changes in function, activity, etc [37][38][40]. 
                                               
 
 
1 Rigorously a nanoparticle can not have any dimension greater than 100 nm. In contrast, the term 
“polymer particles" usually is associated with particles larger than a micron. As the particles used in 
the present project fall between the two categories in terms of size, but largely behave like nano-
species moreso than micro-species, they are defined as nanoparticles. 
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Nanoparticles are usually found as a colloid suspension, where the dispersed solid phase is 
regards to as the internal phase and the continuous phase as the external phase. So 
stability nanoparticles are subjected to colloidal systems laws1. Gold nanoparticles, silver 
nanoparticles, nanoclusters or polymer nanoparticles are some types of nanoparticles with 
interesting properties [20]-[23].    
In the present project only one type of polymer nanoparticles were used, composed 
predominantly by styrene (St) and glycidyl methacrylate (GMA). Since the pioneer synthetic 
method of hollow polymer particles, made of latex, was patented in 1981 [41], there has 
been an exhaustive research and development effort to extend the synthetic techniques and 
application areas [42]-[45]. Because in some cases the diameter of such polymer particles 
have to be less than 1 µm to become useful in bionanotechnology, interfacial 
polymerization, dispersion and suspension processes leading to voided morphology were 
eliminated and only emulsion polymerization was left [46]. A surfactant-free heterogeneous 
polymerization in water solvent is soap-free emulsion polymerization, which is usually 
applied to the production of sub-micrometer-sized polymer particles, as in the present case 
[47]-[49]. The application of this polymerization method to the synthesis of sub-micrometer-
sized particles can overcome the problems of the conventional methods [47][48]. Using 
soap free emulsion polymerization, it is possible to synthesized monodisperse polymer 
nanoparticles with different diameters (100 nm-800 nm) and some reacting groups can be 
introduced on the surface in order to functionalize the polymer nanoparticles [50]. 
2.2. Proteins 
Proteins are biological macromolecules made up by linear chains called polypeptides, which 
in turn are formed by 20 different types of amino acids combined in different order. Amino 
acids are linked together through a peptide bound; a covalent binding between amino group 
of one amino acid and carboxylic group of another. The sequence and type of amino acids 
describe the primary structure of proteins. The peptide chain is then folded up on itself to 
make secondary structure, where the most common models are α-helix and β-sheet. When 
                                               
 
 
1 Detailed information on the stability of nanoparticles in colloidal systems can be found in (Glomm et 
al. 2005) where it is explained the forces presents in the suspension and the mechanism regulating 
the stability, successful defined by DLVO theory. In the present case it is not the aim of the project 
but it is a necessary background. 
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dissolved in water, the secondary structure bends and fold in such a way that the 
hydrophobic groups are buried inside the core of the protein, away from water, while the 
hydrophilic groups turn outwards giving the spatial form of the structure. This last one is 
called tertiary structure and among other things decides the function of proteins [10]-[13] 
[51]-[53]. The tertiary structure of proteins is stabilized by disulfide bonds between 
cysteines, hydrogen bonds between side chains, ionic interactions between side chains, van 
der Waals interactions between side chains and the hydrophobic effect. Finally, some 
proteins are composed for more than one polypeptide and the spatial arrangement of these 
several polypeptides forms the quaternary structure.  
Almost always proteins are surrounding by hydrophilic atmosphere like water. In this 
situation, the interior of proteins consist mostly of non-polar amino acids, where there are in 
contact with other non-polar moites, while the polar side chains are forced away from the 
core to the surface, allowing a lower free energy by interactions and giving stability. This 
bipolarity in the structure is one of the most important properties of proteins.  
2.2.1. Protein stability 
Protein stability is quantitatively described by the standard Gibbs energy change, involved in 
unfolding the unique from three dimensional structure to randomly coiled polypeptide chains 
[54]. Native state is the functional shape that posses a minimum of free energy and is 
related to how tertiary structure is folded. In this state proteins coil up to compact rigid 
structure and play an important role in a wide range of bioprocess. Instead denatured state 
is free and flexible, results in an entropic loss with vital changes in its features and 
unfavourable functional capacity.   
The assumption is that protein can not only exists as either as set of folded conformation or 
set of unfolded conformations, which are separate by energy barriers [55]-[58]. From 
refolding studies, the existence of intermediates has been experimentally established and 
the intermediate conformations have been called the molten globule (MG) states [59]-[61]. 
Molten globules are partially folded states of proteins which are generally believed to mimic 
structures formed during the folding process [61]. MG state conserves native-like secondary 
structure content but without the tightly packed protein interior which leads an enormous 
flexibility and range of motion, keeping almost intact functional capacity [62]. 
Conformational change between the native form and the MG state is reversible [63]. Its 
properties are intermediate between those of native and unfolded protein molecules: it is 
compact and has a number of important features of the native secondary structure and of 
the native overall architecture but has only traces of the detailed native tertiary structure 
[63]. Stable MG state gives the possibility to use interfaces as two-dimensional folding 
template for proteins because of their greater flexibility [14]-[18]. Thus elucidate the 
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structure and the interactions which stabilize molten globule states is a key issue in protein 
folding. The mechanism and pathway of conformational change depend on the amino acid 
sequence of the protein, solvation of hydrophobic side chains, steric hindrance, interaction 
with other amino acid residues or other organic compounds, hydrogen bonding, covalent 
disulfide bonding, and the folding behaviour of helix and sheet microdomains [50]. 
Unfortunately, their dynamic nature, conformational heterogeneity and sometimes limited 
solubility make direct structural studies extremely difficult [64]. 
In case of BSA numerous studies have been done to determinate its structure, its properties 
and even reversible conformational isomerisation with changes in pH (section 2.2.2 BSA 
protein). These studies allow us to ensure that the nanoparticles might be a good tool to 
monitor BSA conformations and features [14]. 
2.2.2. BSA protein  
Bovine serum albumin (BSA) is a serum albumin protein and one of the most widely studied 
proteins [65]-[70].  BSA is commonly used in different biochemical applications because of 
its stability, its lack of effect in many biochemical reactions, and its low cost, since large 
quantities of it can be readily purified from bovine blood, a subproduct of the cattle industry 
[32]. α-La have similar pI to that of BSA (pI 4.8), but with a much smaller molecular mass 
(14,200 Daltons) than BSA (67,000 Daltons) [71]. Maybe α-La is the most well-situated 
protein that could cause apoptosis in tumoral cells in combination with nanoparticles but it is 
quite expensive. Therefore BSA is selected as model protein, although the number of 
surface lysines and the conformations of each protein could be different.  
Table 2.1. Physical properties of BSA [72]. 
Number of amino acids residues 585 
Molecular weight  66.776 Da 
Isoelectric point in water at 25 ºC  4.8  
Dimensions 140 X 40 X 40 Å3 (prolate ellipsoid where a = b < c) 
BSA, as all albumins, is characterized by a low content of tryptophan and methionine and a 
high content of cystine and the charged amino acids, aspartic and glutamic acids, lysine, 
and arginine. The glycine and isoleucine content of BSA are lower than in the average 
protein [73]. Albumins structure is predominantly α-helical with the remaining polypeptide 
occurring in turns and extended or flexible regions between subdomains with no beta-sheets 
[74]. The global structure of BSA is made up of three homologous areas (I, II and III) which 
can be divided into 9 loops by 17 disulphide bonds (Figure 2.1).  Domains I and II and 
domains II and III are connected through helical extensions, creating the two longest helices 
in albumin.  
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Figure 2.1. BSA domains. Adapted from [70]; <http://www.friedli.com/research/PhD/chapter5a.html> [15/01/11]. 
None of the disulphide bonds was accessible to reducing agents in the pH range 5-7, but 
became progressively available as the pH was raised or lowered. Therefore, the disulphides 
in albumin were protected at neutral pH from reducing agents [75]. This is also apparent in 
the structure, which shows that the majority of disulphides are well protected and most are 
not readily accessible to solvent. During unfolding, the conformation of some of the 
disulphide bonds changes. The albumin molecule is not uniformly charged within the 
primary structure, although the tertiary structure seems fairly uniform [74].  
BSA undergoes reversible conformational isomerisation with changes in pH [33][76]. Table 
2.2 and Figure 2.2 shows the conformations and its respectively transitions.  
Table 2.2. Relationship of isomeric forms of bovine serum albumin [33].  
 E form trans F form trans N form trans B form trans A form 
pH  2.7  4.3  8  10  
Name Expanded  Fast  Normal  Basic  Aged 
% α-helix 35  45  55  48  48 
The N-F transition involves the unfolding of domain III. The F form is characterized by a 
dramatic increase in viscosity, much lower solubility, and a significant loss in helical content. 
At pH values lower than 4, albumin undergoes another expansion with a loss of the helical 
extension between domains. This expanded form is known as the (E) form which has an 
increased intrinsic viscosity, and a rise in the hydrodynamic axial ratio from about 4 to 9. At 
pH 9, albumin changes conformation to the basic form (B). If solutions of albumin are 
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maintained at pH 9 and low ionic strength at 3°C for 3 to 4 days, another isomerisation 
occurs which is known as the (A) form. 
 
Figure 2.2. BSA domains [70]. Adapted from [74]; <http://www.friedli.com/research/PhD/chapter5a.html> 
[15/01/11]. 
BSA has two tryptophan residues that possess (Figure 2.3) intrinsic fluorescence [77]. Trp-
134 in the first domain and Trp-212 in the second domain. Trp-212 is located within a 
hydrophobic binding pocket of the protein and Try-134 is located on the surface of the 
molecule. 
 
Figure 2.3. Three-dimensional structures of BSA with tryptophan residues in green colour. Adapted from [78].  
BSA binds free fatty acids, other lipids and flavour compounds, which can alter the 
denaturation of the protein.  Isolated BSA has been reported to be a very functional 
protein. Perhaps, the most outstanding property of albumin is its ability to bind reversibly an 
incredible variety of ligands [32]. 
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2.3. Adsorption of protein on nanoparticles with associated 
structural changes 
Protein adsorption (Figure 2.4) is an interesting but complicated process [79]. Perhaps the 
most intriguing and at the same time the most evasive question is the extent to which the 
molecule undergoes structural alterations. Additional involved subprocess are the 
incorporation (or exclusion) of protons and other ions, dehydration of (parts of) the surface 
and the protein molecule, and the assessment of van der Waals and electrostatic 
interactions among many others [80][81].  
 
Figure. 2.4. BSA-nanoparticle construct. BSA is represented in blue and nanoparticle in green. Adapted from 
<http://www.tainstruments.com/main.aspx?siteid=11&id=263&n=1> [17/01/11]. 
Adsorption of protein at the interface is assumed to pass for three steps: diffusion process 
towards the surface (1), attachment on the surface (2) and spreading on the surface (3) 
[20]. Depending on protein-nanoparticle interaction, it can reach the last step or simply stay 
in the first (attached with partial unfolding, attached or not attached). If the conditions are 
favourable, the adsorption on nanoparticle might affect the tertiary structure of protein, and 
thereby also the function, but without completely denaturation [13][82]. For this reason how 
interaction with interfaces affect the tertiary structure is a relevant factor to study protein-
nanoparticle interaction, in the concrete case of this project BSA-polymer nanoparticle 
interaction.  
In addition to van der Waals and dispersive forces, when a protein attaches to a surface of 
any kind two of the most important adhesion source are: electrostatic bonding and covalent 
bonding [83][84]. The electrostatic bonding is due to attractive/repulsive forces between the 
electrostatic charges of the surface groups of the protein (pH-dependent) and the oppositely 
charge of surface nanoparticles groups. Depending on the charge density and the sign of 
each charge the attachment can be stronger or weaker. On the other hand, if nanoparticles 
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are functionalized with some specific groups it is enable protein immobilization through 
covalent bonding. Lysine, arginine and histidine  residues are often used as covalent 
junction points.The advantageous of covalent bound is a much firmer immobilization, but by 
contrast chemical reactions undergoes concomitant structural alterations. In any case it is 
necessary keep a reasonable dichotomy between retaining a desired functions and securing 
sufficient immobilization without denaturation [85]. The spreading of a protein involves the 
exposure of hydrophobic groups to the surface and forces some functional groups away 
from the core of protein so that they can interact with the surface causing partly 
denaturation [20]. The final solution is to find a balance between the two types of 
attachment, electrostatic and covalent.  
While surface charge and surface groups of polymer nanoparticles define the source of 
attachment, the size is also an important parameter. The curvature of the immobilizing 
agent can influence how much the protein unfolds on the surface. To choose a correct type 
of nanoparticles according to the protein is a key success factor. 
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3. Characterization techniques 
This section seeks to highlight some of the most used analytical techniques in the 
characterization of nanoparticles and protein-nanoparticle construct, in particular those that 
have been used in this work. However, the purpose is not to give a detailed description of 
each one, but only the background needed to understand the methods. In cases where 
further information is required, some important bibliography sources are sited. 
The main analytical techniques to study the features of nanoparticles are: light scattering 
techniques for the hydrodynamic diameter and zeta potential; fluorescence spectroscopy 
respect to conformational changes in proteins; and isothermal titration calorimetry to study 
the reaction kinetics (enthalpy, stoichiometry, equilibrium constant) of protein adsorption.  
3.1. Dynamic light scattering 
The microstructure of colloidal suspension is commonly studied by scattering experiments. 
A considerable amount of theoretical background is needed to extract information about the 
microstructure from the measured scattered intensity, Doppler shifts in the frequency, 
Raman effect in scattered light and to understand such microstructure in terms of properties 
of the suspended particles and the solvent [86][87].  
Scattering (Figure 3.1) is a general physical process in which some forms of radiation 
changes its direction and, on occasion, also its frequency after interacting with the medium. 
In light scattering (LS) process when a light beam incises in a determinate frame the total 
number of photons is unaltered, but the number going in forward direction decreases due to 
redirection of light from scattering interaction. In other words, when light impinges on matter, 
the electric field of the light induces an oscillating polarization of electrons in the molecules 
and these molecules provide a secondary source of light and subsequently scattering light. 
The frequency shifts, the angular distribution, the polarization and the intensity of scattered 
light are determined by the size, shape and molecular interaction in the scattering material 
[88].  
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Figure 3.1. Light scattering phenomena. Adapted from [89]. 
With the aid of electrodynamics and theory dependent of statistical mechanics, light 
scattering give information about the structure and molecular dynamics of the scattering 
medium through the light scattering characteristics of the system1 [88].  
Analytical techniques mentioned below, which were used in the present project are based 
on quasi-elastic light scattering [90]. Zetasizer Nano ZS (Malvern) was the machine 
employed in the project. 
3.1.1. Dynamic light scattering as a particle size determination tool 
Dynamic light scattering (DLS), Photon correlation spectroscopy (PCS) or Quasi-elastic light 
scattering (QELS) is one of the most used methods to determinate the size of particles 
[91][92]. DLS uses the principles of Brownian motion, Rayleigh theory and Mie theory to 
determine the size and molecular weight of particles in a suspension.  
Colloidal sized particles2 in a liquid undergo random motion, also called Brownian motion, 
owing to multiple collisions with the thermally driven molecules of the liquid. In DLS, the 
                                               
 
 
1 Classical light elastic scattering theory was derived by Lord Rayleigh (Rayleigh et al. 1881). New 
theories have been developed to apply a correction for size effect.  Rayleigh-Gans-Debye theory and 
Mie theory (Jennings et al. 1965) involves extrapolation terms and they are an important tools for 
analysing results in colloid solutions and the fundament of different analytical techniques.   
2 A colloid is a substance in the range of nm-µm dispersed evenly throughout another substance. A 
colloidal system consists of two separate phases: a dispersed phase (or internal phase), which is 
usually solid, and a continuous phase (or dispersion medium), which is usually liquid. 
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speed at which the particles are diffusing due to Brownian motion is measured. This is done 
by measuring (Figure 3.2) the rate at which the intensity of the scattered light fluctuates 
when it is detected using a suitable optical arrangement. DLS measures Brownian motion 
and relates this to the size of the particles due to the bombardment by the solvent 
molecules that surrounded them.  
 
Figure 3.2. The basis of DLS: q is the scattering vector,  λ  the wavelength of beam, dp the particle distance, ө 
the angle between light beam and detected scattered light, and G  the correlation equation . Adapted from [91]. 
The relative positions and orientations of the particles undergo Gaussian random changes 
in time (Brownian motion). The result is a total intensity (Figure 3.3) which fluctuates in time 
from zero to double the single particle scattered intensity.  
 
Figure. 3.3. On the left side, the observed signal depends on the phase addition of the scattered light falling on 
the detector. Adapted from [93]. On the middle, fluctuation in the intensity detected from the scattering light in 
different size particle solutions. Adapted from [93]. On the right side, optical configurations of the Zetasizer 
Nano series for dynamic light scattering measurements. Adapted from [93]. 
 
In a real experiment there are perhaps 1010 particles in the scattering volume, and the total 
intensity is the result from the interference between the scattered fields from all of these. As 
a consequence, the intensity I(t, q), as seen by the detector, will be a randomly fluctuating 
signal as shown. The small particles cause the intensity to fluctuate more rapidly than the 
large ones [91][92].  
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Radiating a monochromatic light beam, such as a laser, onto a solution with spherical 
particles in Brownian motion causes a fluctuation in the intensity of the light. This change is 
related to the size of the particle, hence it is possible to compute the sphere size distribution 
and give a description of the particle’s motion.  Note that the diameter that is measured in 
DLS is value that refers to how a particle diffuses within a fluid so it is referred to as a 
hydrodynamic diameter. The diameter that is obtained by this technique is the diameter of a 
sphere that has the same transitorial diffusion coefficient as the particle [92]. 
3.1.2. Laser Doppler electrophoresis as a zeta potential determination tool 
Surface charge of particles [94] is one of the most important parameters in the 
characterization of colloid solutions and can be understood as the electric charge present in 
the interface between two media. Among other things, surface charge of particles in a 
colloid solution determinates the electrostatic force interaction between particles and 
between a particle with its environment, affect the stability of the colloidal system 
determined by Derjaguin-Landau-Verwey-Overbeek theory (DLVO) and it is a essential 
monitoring tool (bonding, attachment, modification, delivery…) of any substance in aqueous 
colloidal systems.  
The most important reference about the surface charge of particles in a colloidal solution is 
the zeta potential value, which can be measured using different techniques, and it is an 
approximation of the real surface charge, as this parameter is not possible to measure. 
More specifically zeta potential is the electrostatic potential that exists between the 
separations of layers surrounding the particle [95]. Colloidal stability in aqueous system is 
related with zeta potential. DLVO theory proposes that the stability of aqueous colloidal 
system in aqueous media is determined by the sum of these electrical repulsive and van der 
Waals attractive forces that exist between particles as they approach each other due to the 
Brownian motion they are undergoing [96][97]. This theory suggests that an energy barrier 
resulting from the repulsive force prevents two particles approaching one another and 
adhering together. But if the particles collide with sufficient energy to overcome that barrier, 
the attractive force will pull them into contact where they adhere strongly and irreversibly 
together. The zeta potential indicates the degree of repulsion between adjacent, similarly 
charged particles in a dispersion. For molecules and particles that are small enough, a high 
zeta potential will confer stability and the solution or dispersion will resist aggregation. When 
the potential is low, attraction exceeds repulsion and the dispersion will break and flocculate.  
1.1.1.1. Double layer theory (DL) and Zeta potential 
The model of the double layer (DL), also called electrical double layer (EDL), is used to 
describe the ionic atmosphere around a charged colloid in an aqueous media and explain 
how electrical repulsion forces  (induced by ions-counterions interaction in the system) 
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operate as a function of distance from the surface of the colloid [95]. It is possible to 
understand this model as a sequence of steps that occurs around negatively charged 
colloid, when the ions that neutralize its charge are attracted to it (Figure 3.4). Theory about 
DL is reviewed in J. Lyklema's Fundamentals of Interface and Colloid Science IV, which 
uses the fundaments of the earliest DL model developed for Helmholtz (Helmoltz et al. 
1853) in combination with Gouy-Chapman-Stern improvements [98]. Necessary 
background that it is needed to understand the fundaments of theory can be found in 
[94][95][99]. The potential drop and the distance from the colloid is an indicator of the 
repulsive force between the colloids as a function of the distance to which these forces 
come into play.  
              
Figure 3.4. On the left side, two ways to visualize the Double Layer. The left view shows the change in charge 
density around the colloid. The right shows the distribution of positive and negative ions around the charged 
colloid. Adapted from [102]. On the right side, representation of zeta potential. Adapted from [102].  
A point of particular interest is the potential that brings together the diffuse and Stern layers. 
This potential is known as the zeta potential, which is important because it can be measured 
in a very simple, while the surface charge and potential can not be measured, and it is a 
good approximation of its. The zeta potential is an effective way to control the behaviour of 
the colloid as it indicates changes in the surface potential and the repulsive forces between 
colloids. 
1.1.1.2. Electrophoresis and Doppler Effect 
Electrophoresis [95] is the movement of charged colloidal particles, immersed in a liquid, 
under the influence of an external electric field. The electrophoretic velocity is the velocity 
during electrophoresis. The electrophoretic mobility is the magnitude of the velocity divided 
by the magnitude of the electric field strength and is direct function of zeta potential. [100]. 
The mobility is counted positive if the particles move towards lower potential (negative 
electrode) and negative in the opposite case. For uniform and not very strong electric field, 
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a linear relationship exists between electrophoretic velocity and the applied field1 (equation 
3.1 and 3.2). 
Eue  )(ve              (equation 3.1) 





 0rseu             (equation 3.2) 
Where ve is the electrophoretic velocity [m s-1]; ue is the electrophoretic mobility [m2 s-1 V-1]; 
E is the electric field strength [V];   is the zeta potential [V]; rs is the relative permittivity of 
the dispersion medium; 0  is the electric permittivity of vacuum [F m
-1];   is the dynamic 
viscosity [Pa s]. In case of Brownian motion, particles do not maintain a steady velocity, 
leading to a broadended spectrum centred on the original laser frequency, the degree of 
broadening begin related to the diffusion coefficient of the species of particles involved. In 
laser Doppler electrophoresis (LDE), the scattering centres are illuminated by a laser whist 
being subjected to an electrical field. The electrophoretic velocity of the scatterings particles 
is determined by measuring the Doppler shift in the frequency of scattered light (equation 
3.3), described by Ware and Flygare (1971) [101].  
evK               (equation 3.3) 
Where K is the magnitude of scattering vector [m-1]. So in this case the important parameter 
is the Doppler shift and not the intensity as in DL [100]. Zeta potential is then calculated 
from electropohretic velocity. Figure 3.5 illustrates the two techniques. 
 
                                               
 
 
1 Electrophoretic velocity is direct function of zeta potential, deduced from Helmholtz-Smoluchowski 
equation (equation. 3.1) respect to electrophoresis. It is not apply in all conditions, Henry’s treatment 
or Obraian-whit can be used in some conditions (Sattelle et al. 1988). 
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Figure 3.5. Schematic representation of experiments designed to monitor secretory granule movements in vitro 
and in vivo. Laser A illuminates suspended secretory granules or isolated nerve terminals. Light scattered at a 
given angle is focused on to the photomultiplier (PMT). This configuration permits quasi-elastic laser light-
scattering (QELS) measurements. Laser B illuminates an electrophoresis cell. Movements of membrane-bound 
particles subjected to an electric field are detected. Scattered light is focused onto the surface of the 
photomultiplier. In this way laser Doppler electrophoresis (LDE) measurements of membrane surface charge 
properties are obtained from secretory granules and plasma membranes. Adapted from [102].  
3.2. Fluorescence spectroscopy 
One of the most important applications of nanoparticles in bionanotechnology, as previously 
reported, is to use them for protein monitoring. Nanoparticles can apply changes to protein 
conformation and, thus, it is possible to alter its functions. The most used technique to study 
these conformational changes in proteins is fluorescence spectroscopy, as some structural 
groups are fluorophores and their fluorescence features depend on protein conformation. 
Fluorescence is a type of luminescence based on the emission of light, according to the 
excited states of atoms, when a specific substance is exposed to light or other 
electromagnetic waves [104]. Fluorescence spectroscopy is primarily concerned with 
electronic and vibrational states (Figure 3.6). First the sample is excited by absorbing a 
photon of light, from baseline to an excited electronic state with vibrational state. The 
molecule then drops back to one of several vibrational levels of basal electronic state, 
emitting a photon in the process (Figure 3.7). Since molecules can fall to any of the different 
levels of vibration in the basal state, the emitted photons have different energies and, 
therefore, frequencies. The emission spectroscopy record these frequencies and intensities 
(Figure 3.8). 
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Figure 3.6. The Einstein coefficients [103]. A21 (s−1) gives the probability per unit time that an electron in state 2 
with energy E2 will decay spontaneously to state 1 with energy E1, emitting a photon (E2 − E1 = hν); B21 
(sr·m2·Hz·W−1·s−1 = sr·m2·J−1·s−1) gives the probability per unit time per unit spectral radiance of the radiation field 
that an electron in state 2 with energy E2 will decay to state 1 with energy E1, emitting a photon; B12 
(sr·m2·Hz·W−1·s−1 = sr·m2·J−1·s−1) gives the probability per unit time per unit spectral radiance of the radiation field 
that an electron in state 1 with energy E1 will absorb a photon and jump to state 2 with energy E2. ni is the 
number density of atoms in state i;  ρ(ν) is the radiation density of the radiation field at the frequency of the 
transition.  
 
Figure 3.7. Jablonski Energy Diagram. Adapted from 
<http://www.olympusmicro.com/primer/java/jablonski/jabintro/index.html> [4/2/2010].  
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Figure 3.8. Schematic representation of fluorescence spectrometer. Adapted from [104].  
In the present work, Fluorolog-3 (Horiba Jobin Yvon, Paris, France) was used to study the 
interaction between BSA and polymer nanoparticles. 
3.2.1. Intrinsic fluorescence of proteins 
Fluorescence is divided into intrinsic (occurs naturally), and extrinsic (added). Proteins 
contain three aromatic amino acid residues (tryptophan, tyrosine, phenylalanine) which may 
contribute to their intrinsic fluorescence [104][105]. These three amino acids have a 
common sequence in that they all contain aromatic ring in their structure that absorbs UV-
light for excitation. The fluorescence of a folded protein is a mixture of the fluorescence from 
individual aromatic residues (Figure 3.9).  
  
Figure 3.9. Amino acids with fluorescent features. Adapted from [105].  
Tryptophan is much more fluorescent than either tyrosine or phenylalanine. Due to this 
greater absorptivity, higher quantum yield, and resonance energy transfer, the fluorescence 
spectrum of a protein containing the three amino acids usually resembles that of tryptophan 
(Table 3.1).  
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Table 3.1. Fluorescent Characterization of the aromatic amino acids [105].  
 Absorption Fluorescence 
Amino acid Wavelength [nm] Molar absorptivity Wavelength [nm] Quantum Yield 
Tryptophan 280 5.600 348 0.20 
Tyrosine 274 1.400 303 0.14 
Phenylalanine 247 200 382 0.04 
However, the fluorescent properties of tryptophan are solvent dependent. As the polarity 
of the solvent decreases, the spectrum shifts to shorter wavelengths and increases in 
intensity. For this reason this method is useful to study the interaction between 
nanoparticles and proteins. If a protein is in folded conformation, tryptophan amino acids 
are in a hydrophobic environment in the core of protein but if the protein is in partially 
unfold form, tryptophan residues are exposed to a more hydrophilic environment in the 
solvent. Tryptophan residues that are exposed to water, have maximal fluorescence at a 
wavelength of about 340-350 nm, whereas totally buried residues fluoresce at about 330 
nm. In fluorescence spectroscopy, protein is generally excited at 280 nm or at longer 
wavelengths, usually at 295 nm to avoid contribution from tyrosine , and with polarization to 
avoid water Raman signal.  
Intrinsic fluorescence of BSA has been also studied [106] and tryptophan is a good 
reference to understand the unfolding state of this protein.  
3.2.2. ANS: fluorescent probe for the characterization of proteins 
Frequently the molecules of interest are not fluorescent or the intrinsic fluorescence is not 
useful for the desired research. In these cases functional fluorescence is obtained by 
labelling molecules with extrinsic probes [104]. For protein it is frequently desirable to label 
them with fluorophores with longer excitation and emission wavelength than the aromatic 
amino acids. Then the labelled protein can be studied in the presence of other unlabeled 
proteins.  
8-anilino-1-naphthalenesulfonic acid (ANS) showed in Figure 3.10 is an extensively utilized 
fluorescent probe for the characterization of protein binding sites (Figure 3.11 and 3.12) 
[107]-[111].  
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Figure 3.10. Chemical structure of ANS and bis-ANS. Adapted from [107].  
ANS is a sulfonated naphthalene with aniline group [107]. The naphthalene group and 
aniline ring are hydrophobic, but sulfonate group has negative charge. Also, amide at the 
aniline ring can provide electrons for hydrogen bond formation with a protein. Therefore 
ANS has both polarity and hydrophobicity. Using the sulfonate group, ANS can interact with 
the positively charge amino acids such lysine, arginine and histidine. In addition, aromatic 
rings of ANS stabilize the binding with apolar sides of protein. The complementary 
interaction of both polar groups and apolar groups is the key component used in the protein 
folding study. In general, native conformation tend to hide their hydrophobic residues inside 
them and, except for some ligand binding sites, proteins have hydrophilic or polar amino 
acids on the surface. The beauty of ANS is that the binding of these molecules with proteins 
requires both the ionic interaction of sulfonate with positively charged amino acids and the 
hydrophobic interaction of aromatic rings with hydrophobic residues in an orientated 
manner. If a protein is denatured, it does not have any organized structure of having both 
charged region and hydrophobic region in a complementary manner. In this scenario, ANS 
bind unstably with the protein by just one form of interaction which leads an easy 
detachment of the dye from the freely moving protein.  
                        
Figure 3.11. On the right side, anion binding of ANS to proteins. Adapted from [109]. On the right side, possible 
fluorescence spectra of ANS. Adapted from [107]. 
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Aromatic rings (aniline and naphtalene) are fluorescent with the energy transfer within the 
molecular electrons. The excitation of ANS is 350-380 nm and the emission maximum in 
water is 500 nm. Interestingly, when ANS binds to protein hydrophobes the emission 
maximum is shifted to blue wavelength range 470 nm aproximatelly and it always come 
along with the huge increase of emission intensity. 
Serum albumins are the most multifunctional proteins known to date and their most 
outstanding property is their ability to reversibly bind an incredible variety of ligands [108].  
 
Figure 3.12. Molecular docking between ANS and BSA. BSA structure was obtained by homology modeling 
using HAS (1BM0) as a template. The domains are colour-coded as follows: I, orange; II, green, and III, blue. 
The subdomains are depicted by different colour values, dark (A) and light (B). The ANS molecules 
successfully docked to BSA are shown in a ball and stick representation coloured red. Adapted from [107]. 
3.3. Isothermal  titration calorimetry  
Calorimetric methods have been an individual tool for understanding the forces that stabilize 
the folded conformations of proteins and has long been used to accurately measure ligand-
binding properties. Isothermal tritration calorymetry (ITC) is a versatile and sensitive 
technique that allows for the simultaneous determination of binding affinity, enthalpy and 
stoichiometry of an interaction. ITC can quickly determine the thermodynamics of an 
interaction under native conditions, without the use of tags or labels that may otherwise 
interfere with binding [112]. 
An ITC instrument (Figure 3.13) consist of two identical cells composed of a highly efficient 
thermal conducting material surrounded by an adiabatic jacket [113][114]. Sensitive 
thermopile/thermocouple circuits detect temperature differences between the two cells and 
between the cells and the jacket. Heaters located on both cells and the jacket are activated 
when necessary to maintain identical temperatures between all components. In an ITC 
experiment, the macromolecule solution is placed in the sample cell. The reference cell 
contains buffer or water minus the macromolecule. Prior to the injection of the titrant, a 
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constant power (<1 mW) is applied to the reference cell. This signal directs the feedback 
circuit to activate the heater located on the sample cell. This represents the baseline signal. 
The direct observable measured in an ITC experiment is the time-dependent input of power 
required to maintain equal temperatures in the sample and reference cell. During the 
injection of the titrant into the sample cell, heat is taken up or evolved depending on whether 
the macromolecular association reaction is endothermic or exothermic. For an exothermic 
reaction, the temperature in the sample cell will increase, and the feedback power will be 
deactivated to maintain equal temperatures between the two cells. For endothermic 
reactions, the reverse will occur, meaning the feedback circuit will increase power to the 
sample cell to maintain the temperature. From several repeat injections, a binding curve can 
be obtained, and the affinity, stoichiometry, and enthalpy change upon binding can be 
derived. 
 
Figure 3.13. ITC mechanism. Adapted from [113]. 
Stoichiometry of the reaction, equilibrium constant and enthalpy of the reaction are the three 
main parameters that can be calculated using ITC [115] . As in case of fluorescence is 
determined the folding or unfolding state of BSA, here it is determined the amount of BSA 
that react and the thermodynamic parameters of the reaction. In the present work Nano ITC 
single injection (TA instruments, Hedehusene, Denmark) has been used to study the 
unfolding of BSA at the surface of polymer nanoparticles. 
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4. Experimental procedure 
This section deals in the procedure followed to study BSA-polymer nanoparticle construct. 
All steps are described in chronological order: synthesis of polymer nanoparticles, 
characterization of polymer nanoparticles, adsorption of BSA on the nanoparticles and 
characterization of native BSA and BSA-polymer nanoparticle constructs.   
4.1. Polymer nanoparticles synthesized by soap free 
emulsion polymerization 
The procedure followed was the same as that used by Yasudas et al. [50]. In the present 
project, two types of negatively charged monodisperse polymer nanoparticles having epoxy 
groups and one type having no epoxy groups were synthesized by soap free emulsion 
copolymerization of glycidyl methacrylate (GMA), styrene (St), divinyl benzene (DVB) and 
ammonium persulfate (APS). Glycidyl methacrylate and styrene were the monomers 
involved in the copolymerization process; divinyl benzene was the cross linker agent; and 
ammonium persulfate was the initiator. In order to introduce epoxy groups and negative 
surface charge on the polymer nanoparticles, glycidyl methacrylate was added to the 
reaction mixture at 2 h from the start of the reaction. Thus the possibility of hydrophobic 
interaction with the core of BSA, which would induce most likely irreversible conformational 
changes, was removed.  The epoxy groups of the polymer nanoparticles were opened using 
strong acid to obtain polymer nanoparticles without epoxy groups.  
4.1.1. Polymer nanoparticles with epoxy groups on the surface 
Polymer nanoparticles for protein immobilization support were synthesized by soap-free 
emulsion polymerization [50]. First, GMA1 (1.8 g, 12.28 mmoles), DVB2 (0.04 g, 0.25 
mmoles), St3 monomer (1.2 g, 11.41 mmoles) and 95 ml of mili Q-water were added to a 
                                               
 
 
1 Glycidyl methacrylate, 97% 
2 Divinylbenzene technical grade, 80% 
3 Styrene, RegeantPlus, >=99% 
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300 ml five-neck reaction flask. Plastic pipettes were used for introducing regents. The 
reaction vessel was immersed in an oil bath at 70 ºC and the reaction mixture was stirred 
between 50 rpm and 100 rpm, depending on the particle size desired, for 15 minutes. When 
the temperature in the reaction mixture reached 70 ºC, APS1 (0.06 g, 0.26 mmoles) 
dissolved in 5 ml of mili-Q water was added to initiate the reaction. 2 h after addition of 
aqueous initiator solution (check the disappearance monomer on the surface), GMA (2.04 
mmoles) was added to the reaction mixture. The reaction mixture was heated for 16 hours 
after addition of aqueous initiator solution. The final solution was white with the intensity of 
the colour proportional to the total amount of polymer nanoparticles. Following 
polymerization, the reaction mixture was centrifuged at 11000 rpm for 30 min, and the 
precipitate polymer nanoparticles were suspended in distiller water. Centrifugation, 
discarding suprenadant and resuspending polymer nanoparticles with distiller water 
(particles washing) was repeated three times. After that polymer nanoparticles were 
resuspended in 80 ml mili-Q water and stocked at 4 ºC approximately.  
4.1.2. Polymer nanoparticles without epoxy groups on the surface  
Polymer nanoparticles with epoxy groups were kept in an aqueous system, 0.2 M of HCl or 
NaOH, for 1 h at 60 ºC in order to open the epoxy groups. After reaction, polymer 
nanoparticles were washed by ammonium hydroxide 0.2 M to exchange counter ions of 

3SO . Finally, centrifugation (11000 rpm 30 min), discarding suprenadant and resuspending 
polymer nanoparticles with distiller water (particles washing) was repeated three times.   
4.1.3. Concentration of polymer nanoparticles 
Polymer nanoparticles concentration was measured by gravimetry. A small portion of 
particles suspension (200 µl) was added to aluminium cup and then it was stored in dry 
oven (60ºC) for 90 min. The difference between cup weight with dry portion of particles and 
cup weight empty gave the amount of nanoparticles in a known volume. The total amount of 
polymer nanoparticles was then calculated by multiplying the concentration by total sample 
volume.  
                                               
 
 
1 Ammonium persulfate, 98+%, A.C.S. reagent 
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4.1.4. Characterization of polymer nanoparticles 
Polymer nanoparticle size and its distribution were measured using a Zetasizer Nano ZS 
(Malvern). A portion polymer nanoparticles solution was loaded into 1 cm x 1 cm 
poly(styrene) cell and automatically measured by the machine. High concentrations of 
polymer nanoparticles showed wrong results since the scattering was affected by the 
interaction of a lot of particles; in that case the sample was diluted (<10 mg/ml). The zeta 
potentials of the polymer nanoparticles were measured using also a Zetasizer Nano ZS 
(Malvern). Here, 15 ml of polymer nanoparticles 3.75 mg/ml adjusted with mili-Q water 10 
mM NaCl was prepared and loaded into the pH titration unit (MPT-2, Malvern). pH of the 
sample solution was varied from 10 to 3 using 0.25 M of hydrochloric acid or 0.25 M of 
sodium hydroxide. Additional volume was considered neglectable. The pH adjusted sample 
solution was circulated in the Zetasizer and zeta potentials at various pH were automatically 
measured.  
4.2. BSA immobilization on polymer nanoparticles  
BSA protein was immobilized on polymer nanoparticles by preparing different solutions of 
BSA 3.6 µM and polymer nanoparticles 3.75 mg/ml. The volume of the sample was 
adjusted using mili-Q water 10 mM NaCl for zeta potential measurements or buffer solutions 
at different pH for fluorescence measurements. The pH of the samples solutions was 
regulated using either sodium acetate (pH 3.8), potassium phosphate (pH 7.4), or sodium 
borate (pH 9.0). It was necessary to wait at least three hours after mixing for equilibrium to 
be reached.  
4.2.1. Characterization of BSA-polymer nanoparticle constructs 
The zeta potentials of BSA and BSA-polymer nanoparticle constructs were measured using 
also Zetasizer Nano ZS (Malvern). In that case 15 ml of sample mixture adjusted with mili-Q 
water 10 mM NaCl were loaded into the pH titration unit (MPT-2, Malvern). Isoelectric point 
was also reported.   
Fluorescence emission spectra were measured using a Fluorolog-3 (Horiba Jobin Yvon, 
Paris, France). Protein solution, or a mixture of protein and particle, in a buffer solution was 
added to 1 cm x 1 cm quartz cell and the detector was placed in the 90o direction against 
excitation beam. All samples containing ANS 17 µM were measured from 385 nm to 700 nm 
with 370 nm as excitation wavelength and slit 1. All samples with no ANS were measured 
from 310 nm to 500 nm at 295 nm and slit 5. The set up with 295 nm was with polarization 
and at 370 nm was without polarization. The reason was that at 295 nm water fluorescence 
could affect the results due to water Raman peak. For calibration, fluorescence emission 
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spectra of the particle suspension in various buffer solutions were also measured. In the 
case of immobilized protein, fluorescence emission spectra included particle contribution for 
fluorescence emission spectra. To obtain fluorescence emission spectra of immobilized 
protein, measured fluorescence emission spectra were numerically extracted from the 
fluorescence emission spectra of particle.  
4.3.  Unfolding of immobilized BSA using urea in combination 
with ANS 
BSA-polymer nanoparticle constructs were also studied by fluorimetry in a different 
denaturation conditions. Urea was used as a denaturation agent to induce the protein 
unfolding [116].  
Different samples BSA 3.6 µM, polymer nanoparticles 3.75 mg/ml and ANS 17 µM in a 
buffer solution with urea were prepared. The concentration of urea varied from 0 M to 8 M. 
Finally, fluorescence spectroscopy was carried out ten minutes after the addition of urea to 
the samples. Protein-polymer nanoparticle solution was loaded into 1 cm x 1 cm quartz cell 
and the detector was placed in the 90o direction against excitation beam. Fluorescence was 
measured with 370 nm as excitation wavelength, slit 1 and without polarization using a 
Fluorolog-3 (Horiba Jobin Yvon, Paris, France). 
4.4. Isothermal titration calorimetry 
Adsorption of BSA on the surface of polymer nanoparticles was finally studied by isothermal 
tritation calorimetry (ITC) using a Nano Isothermal Tritation Calorimeter (TA instruments, 
Hedehusene, Denmark). The experiments were performed at different conditions and in all 
cases BSA was titrated to a sample cell containing polymer nanoparticles. Finally the 
amount of heat derived from the reaction at each titration was recorded by the instrument 
and the enthalpy, the stoichiometry and the equilibrium constant of the reaction were 
automatically calculated.  
Different samples of polymer nanoparticles 3.75 mg/ml in a buffer solution were loaded in a 
943 µl sample cell. The titration was carried out using a 100 µl syringe filled with BSA 36 
µM. 25 titrations of 4 µl every 500 seconds constituted one experiment.        
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5. Results and discussion 
The present section report the results obtained after followed the previous procedure. The 
aim of this is to give a coherent explanation to the results concerning the interaction 
between BSA protein and polymer nanoparticle. 
5.1. Synthesis and characterization of monodisperse polymer 
nanoparticles 
Three different types of monodisperse anionic polymer nanoparticles were synthesized by 
soap free emulsion polymerization: two different size of polymer nanoparticles functionalized 
with epoxy groups and one type of polymer naoparticles without epoxy groups.   
5.1.1. Polymer nanoparticles with epoxy groups 
In order to determine the effect of the agitation speed during the soap free emulsion 
polymerization process in polymer nanoparticles size, four experiments were carried out in a 
batch reactor by soap free emulsion polymerization, two at low stirring rate and two at high 
stirring rate. The two first experiments were at 50 rpm which gives laminar flow during the 
polymerization, while the two last experiments were at 100 rpm, resulting in more turbulent 
flow. Table 5.1 and Figure 5.1 and 5.2 show the average result of each experiment.    
Table 5.1. Average size distribution of monodisperse polymer nanoparticles.  
Stirring 50 rpm* 
Exp. Z-Ave PdI Pk 1 Mean Int Pk 1 Area 
Int 
  d.nm σ  σ d.nm σ % 
1 227 0.85 0.033 0.025 231 2.43 100 
2 212 2.71 0.052 0.017 216 6.37 100 
Stirring 100 rpm* 
Exp. Z-Ave PdI Pk 1 Mean Int Pk 1 Area 
Int 
  d.nm σ  σ d.nm σ % 
1 153 0.146 0.056 0.004 160 3.1 0 
2 139 0.73 0.062 0.017 146 1.06 0 
*Each sample was recorded 3 times and the results are the average of all. 
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Figure 5.1. Size distribution by intensity of monodisperse polymer nanoparticles at 50 rpm. The first one shows 
the results of experiment 1 and the second one the results of experiment 2 from table 5.1. 
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Figure 5.2. Size distribution by intensity of monodisperse polymer nanoparticles 100 rpm. The first one shows the 
results of experiment 1 and the second one the results of experiment 2 from Table 5.1. 
Both experiments, 50 rpm and 100 rpm, showed a very narrow monodisperse size 
distribution. Furthermore really interesting differences could be found. At low stirring the 
diameter of nanoparticles1 were around 227 nm, whereas with increasing the agitation 
speed of the sample the diameter decreased around 153 nm. Therefore by controlling this 
parameter it might be possible to synthesize polymer nanoparticles in a different range of 
diameters. High stirring means more turbulent flow in the batch reactor and more 
polydispersity.  In the range of work this is not a problem, but must be considered when 
working in more drastic conditions. Finally the reproducibility is quite high. When the same 
parameters are used, the results varied with less than 10%.  
                                               
 
 
1 The particle size measured by dynamic light scattering is the hydrodynamic diameter, which can 
exceed the physical diameter for strongly charges particles. Compare the size measured using 
dynamic light scattering and another method like microphotography would be recommended.  
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Process efficiency is also an important parameter.  Polymer nanoparticles concentration 
was measured by gravimetry (section 4.1.3 Concentration of polymer nanoparticles). The 
results (Table 5.2) reported that as the size of nanoparticles increases, also the total 
amount obtained.  
Table 5.2. Obtained amount of polymer nanoparticles by soap free emulsion polymerization.   
Diameter [nm] Concentration [mg/ml] Quantity [g] 
  σ  σ 
227 33.5 0.6 2.7 0.051 
153 15.2 0.8 1.2 0.066 
*The amount of substances used in the experiment is reported in the section 4.1 Polymer nanoparticles 
synthesized by soap free emulsion polymerization. Each experiment was repeated three times and the results 
are the average of all. 
The total mass was reduced 54% in polymer nanoparticles 153 nm when it was compared 
with polymer nanoparticles 227 nm. The main cause of this fact could be explained by a 
lower efficiency in the procedure of centrifugation due to the lower mass of each individual 
particle. Higher speed and/or more time centrifugation should help to obtain more quantity, 
although it affects the polydispersity of the particles.  
Determination of zeta potential of polymer nanoparticles in a wide range of pH using Nano 
ZS Malvern was done in combination with acid-base titration process. The concentration of 
polymer nanoparticles in the sample was adjusted to 3.75 mg/ml. Zeta potential of polymer 
nanoparticles 227 nm and 153 nm was then measured (Table 5.3, Figure 5.3). Finally, in 
order to determine the distribution of zeta potential in the particles, zeta deviation was 
checked (Table 5.3, Figure 5.4).    
Table 5.3. Zeta potential of polymer nanoparticles at different pH.   
Sample polymer nanoparticles 227 nm 3.75 mg/ml 
Record T 
Zeta 
potential 
Zeta 
deviation Mobility Conductivity pH 
 °C mV mV µmcm/Vs mS/cm  
1 25 -27.8 7.55 -2.18 1.44 8.91 
2 25 -27.2 7.77 -2.13 1.42 8.83 
3 25 -27.5 7.14 -2.16 1.42 8.75 
4 25 -26.7 6.02 -2.1 1.43 7.81 
5 25 -26.5 7.9 -2.08 1.42 7.75 
6 25 -27.5 7.5 -2.16 1.42 7.72 
7 25 -25.1 6.2 -1.96 1.43 6.63 
8 25 -25.0 7.16 -1.96 1.42 6.68 
9 25 -25.6 7.59 -2.01 1.42 6.71 
10 25 -26.2 6.04 -2.05 1.43 6.10 
11 25 -24.8 7.28 -1.95 1.42 6.15 
12 25 -25.7 6.44 -2.02 1.42 6.19 
13 25 -23.5 6.88 -1.84 1.43 4.99 
14 25 -24.6 7.28 -1.93 1.43 5.06 
Protein-nanoparticle constructs for intracellular delivery  p. 45 
 
15 25 -23.1 6.82 -1.81 1.43 5.10 
16 25 -24.6 4.77 -1.93 1.45 4.19 
17 25 -25.1 4.73 -1.96 1.45 4.20 
18 25 -24.1 4.62 -1.89 1.45 4.22 
19 25 -24.2 6.17 -1.89 1.87 3.08 
20 25 -22.8 5.43 -1.78 1.87 3.08 
21 25 -23.0 6.9 -1.80 1.86 3.09 
22 25 -14.7 14 -1.15 8.60 2.06 
23 25 -13.1 16.9 -1.03 8.78 2.06 
24 25 -16.0 13.3 -1.26 8.76 2.06 
Sample polymer nanoparticles 153 nm 3.75 mg/ml 
Record T 
Zeta 
potential 
Zeta 
deviation Mobility Conductivity pH 
 °C mV mV µmcm/Vs mS/cm  
1 25 -23.2 8.75 -1.82 1.42 9.13 
2 25 -24.5 9.72 -1.92 1.41 9.09 
3 25 -22.6 8.97 -1.77 1.41 9.06 
4 25 -23.6 8.98 -1.85 1.42 8.06 
5 25 -23.9 10 -1.88 1.41 8.01 
6 25 -23.4 8.52 -1.83 1.41 7.95 
7 25 -22.3 8.41 -1.75 1.42 6.59 
8 25 -22.3 8.36 -1.75 1.41 6.66 
9 25 -20.9 9.26 -1.64 1.41 6.71 
10 25 -21.5 8.83 -1.68 1.43 5.17 
11 25 -21.1 8.82 -1.65 1.42 5.32 
12 25 -21.5 9.01 -1.68 1.42 5.40 
13 25 -20.2 8.31 -1.59 1.43 5.03 
14 25 -20.7 8.93 -1.62 1.42 5.08 
15 25 -21.4 7.68 -1.68 1.43 5.12 
16 25 -19.2 5.92 -1.51 1.46 4.14 
17 25 -18.4 7.28 -1.45 1.46 4.15 
18 25 -18.6 6.4 -1.46 1.46 4.16 
19 25 -17.8 5.05 -1.39 1.86 3.12 
20 25 -17.3 6.24 -1.36 1.86 3.11 
21 25 -17.8 6.37 -1.40 1.86 3.11 
22 25 -11.1 16 -0.87 10.2 2.25 
23 25 -10.8 16.6 -0.843 10.5 2.28 
24 25 -10.7 13.6 -0.836 10.4 2.26 
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Figure 5.3. Isoelectric titration graph. Zeta potential at different pH of two samples of polymer nanoparticles. 
Green line refers to diameter 227 nm while red line refers to 153 nm. 
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Figure 5.4. Zeta potential distribution. Zeta potential at pH 7 of 227 nm polymer nanoparticles.  
The polymer nanoparticles with epoxy groups remained negatively charged throughout the 
entire pH region studied here, with the value of zeta potential decreasing by increasing pH 
values as it was expected. The zeta potential distribution of the samples at a specific pH 
was also quite narrow, which means that all particles had the same charge as shown in 
Figure 5.4. There was no isoelectric point and the polymer nanoparticles did not show 
amphoteric conduct.  At pH below three they became useless and the results were far from 
the trend line. Thus, surface charge could be considered homogeneous in polymer 
nanoparticles and it was possible to use them in non-extreme pH conditions. Zeta potential 
of polymer nanoparticles 227 nm was slightly more negatively than polymer nanoparticles 
153 nm. Large particles give room for more negative groups at the surface. In any case 
both polymer nanoparticles could be used as a stable support for protein immobilization. It is 
Protein-nanoparticle constructs for intracellular delivery  p. 47 
 
important to note that the negative charge is a combination of the charges brought by the 
epoxy surface groups plus other surface anionic groups, especially porvided by oxygen 
atoms from glycidyl methacrylte.  
5.1.2. Polymer nanoparticle without epoxy groups 
Epoxy groups were removed from polymer nanoparticles 227 nm, as described in section 
4.1.2 Polymer nanoparticles without epoxy groups on the surface. Thereby it was possible 
to produce negatively charged nanoparticles that allowed a purely electrostatic interaction 
with BSA protein since covalent links had been removed. Table 5.4 and Figure 5.5 show the 
results of the polymer nanoparticles before and after the removal process.  
Table 5.4. Average size distribution of monodisperse polymer nanoparticles before and after removing the epoxy 
groups.  
Sample polymer nanoparticles 227 nm*  
 Z-Ave PdI Pk 1 Mean Int Pk 1 
Area Int 
  d.nm σ  σ d.nm σ % 
Before 227 0.85 0.033 0.025 231 2.43 100 
After 224 1.73 0.036 0.025 227 3.95 100 
*Each sample was recorded 3 times and the results are the average of all. 
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Figure 5.5. Size distribution by intensity of monodisperse polymer nanoparticles before and after removing the 
epoxy groups.  
Protein-nanoparticle constructs for intracellular delivery  p. 48 
 
The sample remained practically unchanged. Opening of epoxy rings in a strongly acidic 
medium (0.2 M HCl) and subsequent washing with ammonium hydroxide (0.2 M NH4OH) 
and mili-Q water did not affect particles size as showed the results. Therefore it was 
possible to create particles with and without epoxy groups alike. However, it is necessary to 
clarify that a significant amount of particles, the order of 26 %, was lost in the re-washing 
process of these after opening the epoxy groups. Higher speed centrifugation should be 
studied.  
Zeta potential was determined following the same technique as for the previous case. But in 
this case pH was adjusted manually and not by acid-base titration machine, which implying 
some differences in the exact points of measurement. This does however not affect the 
results. Table 5.5 shows zeta potential of 227 nm polymer nanoparticles without epoxy 
groups and Figure 5.6 compares the three different particles. 
Table 5.5. Zeta potential of polymer nanoparticles without epoxy groups at different pH.   
Sample polymer nanoparticles 227 nm without epoxy groups  3.75 mg/ml 
Record T 
Zeta 
potential 
Zeta 
deviation Mobility Conductivity pH 
 °C mV mv µmcm/Vs mS/cm  
1 25 -26 7.21 -2.04 1.83 9.13 
2 25 -27.4 5.95 -2.14 1.98 9.13 
3 25 -28 7.3 -2.2 2.01 9.13 
4 25 -25.3 7 -1.99 3.24 7.38 
5 25 -25.6 7.1 -2.01 1.75 7.01 
6 25 -25.5 8.4 -2.00 1.90 7.01 
7 25 -24.1 8.16 -1.89 1.80 5.94 
8 25 -22.5 5.87 -1.76 1.81 5.02 
9 25 -19.6 9.26 -1.54 2.29 3.22 
10 25 -19.6 9.89 -1.54 2.29 3.22 
11 25 -18.5 8.93 -1.45 2.49 2.62 
12 25 -19.8 7.12 -1.55 2.52 2.62 
13 25 -19.3 13.6 -1.52 4.08 2.21 
14 25 -20.3 10.1 -1.59 4.16 2.21 
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Figure 5.6. Isoelectric titration graph. Zeta potential at different pH of tow samples of polymer nanoparticles. 
Green line refers to diameter 227 nm with epoxy groups while dark green line refers to 227 nm without epoxy 
groups.  
Polymer nanoparticles still had negative surface charge after the process, which means that 
this fact was not caused only by epoxy groups. From titration graphic (Figure 5.6), it could 
also observe that there were not so many differences between polymer nanoparticles with 
epoxy groups and without epoxy groups. Small changes indicated that the particles actually 
had experienced alteration, supposedly caused by the removal of these surface groups. 
Trend line of zeta potential value when pH decreases was much more linear and at extreme 
pH conditions seemed that polymer nanoparticles without epoxy groups were less altered. 
For this reason it was possible to synthesize polymer nanoparticles that could interact with 
BSA protein just by electrostatic force. 
Hence, it is possible to make polymer nanoparticles with diverse sizes and different 
interaction forces. Changes in the diameter of nanoparticles provide different curvature and 
unfolding states in BSA protein. Also depending on the type of bonding, covalent or 
electrostatic, BSA protein can be just adsorbed, adsorbed and unfolded or not adsorbed. 
Variety in nanoparticles means variety in tools we have and more likely to find one that 
satisfy the needs required.  
5.2. BSA immobilization on monodisperse polymer 
nanoparticles. Zeta potential titration measurements. 
Proteins can interact with polymer nanoparticles in different ways. In case of BSA protein 
attached on polymer nanoparticles electrostatic bonding is the main probably hypothesis 
(section 2.3 Adsorption of protein on nanoparticles with associated structural changes). The 
attraction between positively charge surface residues of protein, which are pH-dependent, 
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and the oppositely charges passivation ligands on polymer nanoparticles are responsible for 
this phenomena. If polymer nanoparticles are also functionalized with epoxy groups, which 
can react with amino groups such as lysine, histidine or arginine on the protein surface, then 
the attachment is complemented with covalent bonding and the interaction is stronger, with 
a greater importance in the structural modification of BSA protein. Under different pH 
conditions, BSA experiment reversibly conformational isomerisation (section 2.2.2 BSA 
protein). Finally BSA is a well documented protein and therefore a valid tool in the study 
protein-polymer nanoparticle study (section 2.2.2 BSA protein). 
From global charge it is expected that polymer nanoparticles are more efficient at 
immobilizing BSA below pI as in this environment electrostatic attraction is favourable. In 
addition among all nanoparticles those with big size and epoxy groups should show better 
results for its stronger attachment. Here different experiments at different pH and 
concentrations have been done.  
5.2.1. Zeta potential titration measurements of BSA-polymer nanoparticle 
constructs 
Zeta potential of BSA-polymer nanoparticle constructs was measured in different pH using 
Nano ZS Malvern in combination with acid-base titration process. Four samples of 15 ml 
were measured. The first one contained 3.6 µM of BSA protein. The remaining three 
contained, in addition to protein, 3.75 mg/ml of three different polymer nanoparticles: 
polymer nanoparticles 227 nm with epoxy groups, polymer nanoparticles 153 nm with epoxy 
groups and polymer nanoparticles 227 nm without epoxy groups. Table 5.6 shows zeta 
potential results, Figure 5.7 compare the behaviour at different polymer nanoparticles size 
and Figure 5.8 between polymer nanoparticles with and without epoxy groups. 
Table 5.6. Zeta potential of  BSA--polymer nanoparticle constructs. Polymer nanoparticles 227 nm and polymer 
nanoparticles 153 nm.   
Sample BSA 3.6 uM   
Recor
d T 
Zeta 
potential 
Zeta 
deviation Mobility Conductivity pH 
 °C mV mV µmcm/Vs mS/cm  
1 25 -34.3 8.81 -2.69 1.36 8.99 
2 25 -34.6 7.8 -2.71 1.35 8.92 
3 25 -33.6 8.2 -2.63 1.35 8.84 
4 25 -34.6 9.83 -2.71 1.36 7.72 
5 25 -31 7.17 -2.43 1.35 7.68 
6 25 -32.1 6.55 -2.52 1.35 7.64 
7 25 -31.5 6.93 -2.47 1.36 7.06 
8 25 -29.4 7 -2.3 1.35 7.06 
9 25 -29.8 6.85 -2.34 1.35 7.07 
10 25 -21.7 4.98 -1.7 1.36 6.1 
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11 25 -21.8 5.18 -1.71 1.36 6.17 
12 25 -21.3 5.19 -1.67 1.36 6.21 
13 25 -9.73 4.15 -0.763 1.37 5.21 
14 25 -8.84 4.44 -0.693 1.37 5.24 
15 25 -8.87 4.11 -0.695 1.37 5.26 
16 25 16.3 3.85 1.27 1.41 4.13 
17 25 16.5 4.03 1.29 1.4 4.14 
18 25 16.5 4.36 1.29 1.41 4.14 
19 25 26.5 4.77 2.08 1.8 3.07 
20 25 27.2 4.86 2.13 1.81 3.07 
21 25 26.4 4.48 2.07 1.81 3.07 
22 25 24.2 11.6 1.89 7.99 2.04 
23 25 23.7 11 1.85 8.06 2.03 
24 25 25.2 9.32 1.98 8.06 2.02 
Sample BSA 3.6 uM and polymer nanoprticles 227 nm with epoxy groups 3.75 mg/ml 
Recor
d T 
Zeta 
potential 
Zeta 
deviation Mobility Conductivity pH 
 °C mV mV µmcm/Vs mS/cm  
1 25 -26.5 5.61 -2.08 1.25 9.38 
2 25 -26 6.8 -2.04 1.23 9.33 
3 25 -26.6 7.37 -2.09 1.24 9.29 
4 25 -26.7 6.83 -2.1 1.26 7.76 
5 25 -26.7 6.47 -2.09 1.26 7.73 
6 25 -25.9 7.37 -2.03 1.26 7.69 
7 25 -25.7 6.53 -2.01 1.28 6.8 
8 25 -25.5 6.08 -2 1.27 6.82 
9 25 -25.2 6.65 -1.98 1.27 6.83 
10 25 -24.8 7.25 -1.94 1.29 6.01 
11 25 -25.3 7.02 -1.99 1.28 6.04 
12 25 -22.7 7.15 -1.78 1.28 6.06 
13 25 -22.5 5.92 -1.77 1.3 5.17 
14 25 -19.9 5.46 -1.56 1.29 5.19 
15 25 -19.2 5.78 -1.5 1.29 5.2 
16 25 8.88 5.99 0.696 1.35 4.02 
17 25 9.97 5.79 0.781 1.34 4.03 
18 25 10.1 6.33 0.792 1.34 4.04 
19 25 22.8 12.3 1.79 1.75 3.07 
20 25 22.7 12.3 1.78 1.75 3.07 
21 25 22.1 12.9 1.73 1.75 3.07 
22 25 22.8 18.5 1.79 8.73 2.06 
23 25 23.9 19.1 1.88 8.77 2.05 
24 25 21.5 19.8 1.69 8.76 2.05 
Sample BSA 3.6 uM and polymer nanoprticles 153 nm with epoxy groups 3.75 mg/ml 
Recor
d T 
Zeta 
potential 
Zeta 
deviation Mobility Conductivity pH 
 °C mV mV µmcm/Vs mS/cm  
1 25 -24 8.32 -1.88 1.31 8.89 
2 25 -24.2 8.85 -1.89 1.3 8.84 
3 25 -25.1 10.4 -1.97 1.3 8.78 
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4 25 -23.8 7.7 -1.86 1.32 7.69 
5 25 -24.2 8.85 -1.9 1.31 7.66 
6 25 -23 9.98 -1.8 1.32 7.63 
7 25 -21.9 9.05 -1.71 1.33 6.8 
8 25 -22.6 8.92 -1.77 1.32 6.83 
9 25 -22.9 8.69 -1.79 1.33 6.84 
10 25 -21.5 8.22 -1.68 1.34 5.96 
11 25 -20.8 8.98 -1.63 1.33 6.01 
12 25 -20.7 8.25 -1.62 1.33 6.04 
13 25 -18.1 7.3 -1.42 1.34 5.11 
14 25 -17.9 6.44 -1.4 1.34 5.14 
15 25 -17.4 7.13 -1.36 1.34 5.16 
16 25 4.95 5.18 0.388 1.39 4.06 
17 25 5.89 5.57 0.462 1.38 4.07 
18 25 5.82 4.86 0.456 1.38 4.08 
19 25 20.5 14.4 1.61 1.81 3.1 
20 25 19.4 16.3 1.52 1.8 3.1 
21 25 19.3 15.9 1.51 1.8 3.1 
22 25 18.4 17.9 1.44 9.88 2.08 
23 25 20.4 21 1.6 9.92 2.08 
24 25 18 22.8 1.41 9.92 2.11 
Sample BSA 3.6 uM and polymer nanoprticles 227 nm without epoxy groups 3.75 mg/ml 
Recor
d T 
Zeta 
potential 
Zeta 
deviation Mobility Conductivity pH 
 °C mV mV µmcm/Vs mS/cm  
1 25 -26.1 8.2 -2.05 1.65 9.56 
2 25 -26.5 7.05 -2.08 1.78 9.56 
3 25 -27.8 6.26 -2.18 1.4 8.4 
4 25 -28 7.01 -2.2 1.51 8.4 
5 25 -26.8 7.74 -2.1 1.43 6.54 
6 25 -26.9 6.44 -2.11 1.52 6.54 
7 25 -24 7.83 -1.88 1.35 6.05 
8 25 -19.8 6.42 -1.55 1.39 4.91 
9 25 -12.3 6.89 -0.968 1.38 4.55 
10 25 21.2 9.42 1.67 1.61 3.05 
11 25 21.3 10.6 1.67 1.67 3.05 
12 25 26.2 8.89 2.05 2.53 2.48 
13 25 26.3 7.95 2.06 2.58 2.48 
14 25 26.4 14.1 2.07 2.49 2.48 
15 25 24.5 8.32 1.92 2.38 2.48 
16 25 24.4 10.3 1.92 2.27 2.48 
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Figure  5.7. Isoelectric titration graph. Zeta potential at different pH of three samples of BSA+PP with epoxy 
groups. Size comparison. Blue line refers to BSA, green line to BSA+PP 227 nm and red line BSA+PP 153 nm.  
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Figure  5.8. Isoelectric titration graph. Zeta potential at different pH of three samples of BSA+PP 227 nm. Surface 
groups comparison. Blue line refers to BSA, green line to BSA+PP with epoxy groups and dark green line 
BSA+PP without epoxy groups.  
BSA protein had isoelectric point at 4.84(±0.05). The value reduced until 4.40(±0.10), 
4.32(±0.15) and 4.00(±0.10) when immobilized on polymer nanoparticles 227 nm with epoxy 
groups, 153 nm with epoxy groups and 227 nm without epoxy groups respectively. The 
changes in pI indicated that BSA protein suffered an alteration due to the interaction with 
anionic polymeric surface of nanoparticles. Unfortunately the grade of interaction can not be 
related to the sizes of nanoparticles since the shifts were almost the same and the results 
overlapped if the uncertainties were accounted (Figure 5.7). In contrast there existed some 
variation between polymer particles with epoxy groups and polymer particles without epoxy 
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groups (Figure 5.8). Polymer nanoparticles without epoxy groups seemed to alter the pI of 
the sample more. This fact reveals differences in the attachment of BSA on the polymer 
nanoparticles according to the surface groups. Thus the conclusion which derives is that 
exist some interaction between polymer nanoparticles and BSA protein and some 
differences in this interaction depending on the type of nanoparticles.  
To further detail this information it is also requested to know the degree of conformational 
changes and the amount of protein attached. Fluorescence spectroscopy (section 5.3 
Fluorescence spectroscopy of BSA-polymer nanoparticle constructs) and ITC (section 5.5 
Studies of immobilized BSA by isothermal titration calorimetey) measurements are two tools 
used to obtain more detailed information.  
5.3. Fluorescence spectroscopy of BSA-polymer nanoparticle 
constructs 
Fluorescence spectroscopy is regarded as a good system to evaluate conformational 
changes in BSA protein. BSA has two tryptophan (Trp) residues responsible for the 
fluorescence as it has been already mentioned: one embedded in the hydrophobic 
environment in the core and one which is present on the surface (section 2.2.2 BSA 
protein). Unfolding grade of BSA induces changes in the microenvironment surrounding 
these residues and result in a shift in the intrinsic fluorescence emission of the protein. The 
same occurs when a probe like ANS is used in extrinsic fluorescence. Here some tests 
were done with polymer nanoparticles at various pH. To prevent pH changes attributed to 
the counter ions of the ionic polymer nanoparticles, three kinds of buffer solutions were 
used; at pH 3.8 (sodium acetate buffer), 7.4 (potassium phosphate buffer), and 9.0 (sodium 
borate buffer). When BSA was immobilized on polymer nanoparticles in sodium acetate 
buffer (pH 3.8), the polymer nanoparticles precipitated slowly in the course of few minutes. 
This indicates that the protein-nanoparticle constructs formed by the polymer nanoparticles 
softly aggregated, with the positive charge of immobilized BSA acting as a bridge between 
negatively charged particles [50]. 
5.3.1. Intrinsic and extrinsic fluorescence of polymer nanoparticles 
Fluorescence emission spectra of polymer nanoparticles 3.75 mg/ml were measured at 
three different pH (3.6, 7.4 and 9). Figure 5.9 show the results of intrinsic fluorescence and 
Figure 5.10, 5.11 and 5.12 the results of extrinsic ANS fluorescence.     
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Figure 5.9. Intrinsic fluorescence emission spectra of polymer nanoparticles at different pH. The concentrations 
used were: polymer nanoparticles 3.75 mg/ml, ANS 0 µM. Excitation wavelength 295 nm, slit 5, polarization 90º.   
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Figure 5.11. Extrinsic ANS fluorescence emission spectra of polymer nanoparticles at pH 3.8. The 
concentrations used were: polymer nanoparticles 3.75 mg/ml, ANS 17 µM. Excitation wavelength 370 nm, slit 1, 
without polarization.   
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Figure 5.11. Extrinsic ANS fluorescence emission spectra of  polymer nanoparticles at pH 7.4. The 
concentrations used were: polymer nanoparticles 3.75 mg/ml, ANS 17 µM. Excitation wavelength 370 nm, slit 1, 
without polarization.   
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Figure 5.12. Extrinsic ANS fluorescence emission spectra of polymer nanoparticles at pH 9. The concentrations 
used were: polymer nanoparticles 3.75 mg/ml, ANS 17 µM. Excitation wavelength 370 nm, slit 1, without 
polarization.   
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Intrinsic fluorescence of polymer nanoparticles did not depend on pH. In this case spectra 
only changed if polymer nanoparticles were different and not with respect of pH at which the 
samples was as it can be seen in Figure 5.9. This fact indicates that polymer nanoparticles 
were stable throughout the pH-range. Wavelength of maximum intensity increased 15-20 
nm by decreasing the size of nanoparticles. In the case of nanoparticles with the same size 
those without epoxy groups presented more intensity in the emission spectra without 
changing the wavelength of maximum emission. In reference to extrinsic fluorescence 
opposite happens. Fluorescence was pH-dependent, highest at pH 7.4 and minimum at pH 
9, and it did not depend on polymer nanoparticles size with the wavelength at maximum 
intensity around 465 nm in all cases. Polymer nanoparticles were not porous [50] but it 
could be possible that ANS bound on the surface in such a way that the fluorescence 
emission increased, allegedly with greater intensity at pH 7.4, or it could also be an effect of 
using different buffers. Unlike the previous case, polymer nanoparticles without epoxy 
groups presented bigger discrepancy by decreasing pH, with higher emission intensity 
(Figure 5.11). The reason could be that in polymer nanoparticles without epoxy groups 
charge changed more with pH due to protonation/deprotonation. This could affect possible 
bindingsites for ANS. Epoxy groups are not that dependent of pH, so ANS no matter which 
pH at least be able to bind to the epoxy groups. 
The most interesting information is the fluorescence of BSA protein and not the 
fluorescence of polymer nanoparticles. However, it is necessary to know this last one to 
eliminate the interference of polymer nanoparticles and to study only changes in BSA 
protein.   
5.3.2. Intrinsic and extrinsic fluorescence of BSA 
BSA Trp fluorescence and BSA extrinsic ANS fluorescence emission spectra were studied 
at pH 3.8, 7.4 and 9. Three samples BSA 3.6 µM at each pH were done and measured. 
Figure 5.13 show obtained results in intrinsic fluorescence and Figure 5.14 results in 
extrinsic fluorescence. 
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Figure.  5.13. Intrinsic fluorescence emission spectra of BSA at different pH. The concentrations used were: BSA 
3.6 µM, ANS 0 µM. Excitation wavelength 295 nm, slit 5, polarization 90º.   
Li et al. 2007 [65] have reported BSA Trp fluorescence spectra in phosphate buffer at the 
same pH noted above, where it was found that fluorescence intensity was inversely 
correlated to pH value, with the intensity at pH 9 being the lowest. However, Yasuda et al. 
[50] found that BSA fluorescence intensity was at a maximum at pH 7.4 and attributed the 
discrepancy to differences in buffer systems used between studies.  In the present work the 
buffer solutions that were used were the same as Yasudas et al. [50] work for this reason 
the maximum intensity was at pH 7.4 and the minimum at pH 9, being at pH 3.8 in an 
intermediate level. The maximum emission peak positions at pH 3.8, 7.4, and 9 were 358, 
366, 358 nm, respectively. It was around 10 nm higher than expected [65][50] but the 
parameter that gives us information is the difference and not the value, so this fact does not 
alter the conclusions. Finally, it should be mentioned that variation in BSA emission maxima 
at different pH could be related to conformational isomerisation induced by the conditions in 
which the protein was subjected. At pH 7.4 BSA was in native form and the emission 
intensity was maximum. At pH 3.8 and pH 9 it was in partially unfolded conformations, F 
form and B form respectively, and the fluorescence intensity decreased (section 2.2.2 BSA 
protein).    
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Figure 5.14. Extrinsic ANS fluorescence emission spectra of BSA at different pH. The concentrations used were: 
BSA 3.6 µM, ANS 0 µM. Excitation wavelength 295 nm, slit 5, polarization 90º.   
BSA extrinsic fluorescence emission spectra (Figure 5.14) did not change significantly with 
the pH and just to clarify that at high pH the intensity decreased. It is known that ANS buried 
by hydrophilic environment has its maximum emission at 500 nm while if it is in hydrophobic 
atmosphere the value shifts to shorter wavelength. In all cases the maximum was around 
470 nm and therefore BSA protein was not unfolded and ANS surrounded by non-polar 
groups. We expect that BSA-polymer nanoparticles constructs show a low increase in the 
corresponding wavelength.   
All modifications produced by mixing BSA protein with the particles are studied in later 
sections.  
5.3.3. Intrinsic and extrinsic fluorescence of BSA-polymer nanoparticle 
constructs. Particles size comparison. 
Different BSA-polymer nanoparticle construct were done in order to elucidate the effect of 
polymer nanoparticles in BSA protein conformation. Two different types of polymer 
nanoparticles with epoxy groups were chosen; polymer nanoparticles 227 nm and polymer 
nanoparticles 153 nm. It is expected a covalent binding with lysine, histidine and arginine 
residues on the protein. Table 5.7 shows all the samples and its composition.  
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Table 5.7. BSA-polymer nanoparticle constructs. Polymer nanoparticles 3.75 mg/ml, BSA 3.6 µM. Size 
comparison. 
Sample pH Polymer nanoparticles type 
1 3.8 Polymer nanoprticles 227 nm with epoxy groups 
2 7.4 Polymer nanoprticles 227 nm with epoxy groups 
3 9 Polymer nanoprticles 227 nm with epoxy groups 
4 3.8 Polymer nanoprticles 153 nm with epoxy groups 
5 7.4 Polymer nanoprticles 153 nm with epoxy groups 
6 9 Polymer nanoprticles 153 nm with epoxy groups 
Each sample was divided in two and half mixed with ANS 17 µM. Finally fluorescence 
emission spectroscopy was completed and the results compared with the spectra of BSA 
obtained in the previous section. Constant spectra of polymer nanoparticles were subtracted 
from the diminished spectra of the protein. Figure 5.15 shows the results of intrinsic 
fluorescence and Figure 5.16 the result of extrinsic fluorescence. 
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Figure 5.15. Intrinsic fluorescence emission spectra of BSA in the presence and absence of polymer 
nanoparticles at different pH. The concentrations used were: polymer nanoparticles 227 nm with epoxy groups 
3.75 mg/ml (if it corresponds), BSA 3.6 µM, ANS 0 µM. Excitation wavelength 295 nm, slit 5, polarization 90º. 
Constant spectra of polymer nanoparticles were subtracted from the diminished spectra of the protein.  
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Figure 5.16 Intrinsic fluorescence emission spectra of BSA in the presence and absence of polymer 
nanoparticles at different pH. The concentrations used were: polymer nanoparticles 153 nm with epoxy groups 
3.75 mg/ml (if it corresponds), BSA 3.6 µM, ANS 0 µM. Excitation wavelength 295 nm, slit 5, polarization 90º. 
Constant spectra of polymer nanoparticles were subtracted from the diminished spectra of the protein.  
Concerning the intrinsic fluorescence, all samples with only BSA showed more intensity at 
all pH, regardless of the size of nanoparticles. This is a signal which could confirms that Trp 
residues of BSA protein were exposed to more hydrophilic environment when interacted 
with nanoparticles. However polymer nanoparticles can acts as a quencher, as well as it 
provides scattering which might reduce the signal. The emission wavelength also 
experienced changes. With the exception of acidic pH, which did not shift the emission 
maxima, the wavelength of maximum intensity increased until approximately 385 nm in pH 
7.4 and pH 9 with respect to the signals of free BSA at these pH. The red shift of the 
maximum emission could mean a hydrophilic shift in the microenvironment surrounding the 
Trp residues of immobilized BSA, which might be attributed to partial unfolding of the protein 
[65]. Using these techniques it was not possible to determine the total amount of free or 
attached BSA protein but the method confirmed that conformational changes exist. It seems 
that the most important alterations occurred at pH 7.4, followed by pH 9, and finally at pH 
3.8 it was quite more difficult to find any pattern and BSA could be only attached and not 
unfolding. Regarding the results between polymer nanoparticles 227 nm and polymer 
nanoparticles 153 nm, no significant changes were observed. Induced modifications in BSA 
proteins were more or less equivalent as there were not differences in wavelengths. The 
signal strength was weaker in small particles than in large particles. It could be related to the 
number of attached protein and not to conformational changes. With the same amount of 
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polymer nanoparticles the number and the surface area of small particles should be higher 
than the number and the surface area of large polymer nanoparticles. 
It can be concluded that polymer nanoparticles with epoxy groups induce pH-dependent 
alterations in BSA proteins, beforehand with greater impairment at pH 7.4 and these 
changes can not be related to the size of the particles in the range of study.  
Below the results of ANS fluorescence are shown (Figure 5.17 and 5.18). In contrast to the 
previous case, here the emission spectra are presented in two graphics; one with the 
constant spectra of polymer nanoparticles subtracted from the diminished spectra of the 
protein and another without any subtraction. 
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Figure 5.17. Extrinsic ANS fluorescence emission spectra of BSA in the presence and absence of polymer 
nanoparticles at different pH. The concentrations used were: polymer nanoparticles 227 nm with epoxy groups 
3.75 mg/ml (if it corresponds), BSA 3.6 µM, ANS 17 µM. Excitation wavelength 370 nm, slit 1, without 
polarization. Graphic 1 show the results with the constant spectra of polymer nanoparticles subtracted from the 
diminished spectra of the protein. Graphic 2 show the results without the constant spectra of polymer 
nanoparticles subtracted from the diminished spectra of the protein. 
Signal of PP subtracted 
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Figure. 5.18 Extrinsic ANS fluorescence emission spectra of BSA in the presence and absence of polymer 
nanoparticles at different pH. The concentrations used were: polymer nanoparticles 153 nm with epoxy groups 
3.75 mg/ml (if it corresponds), BSA 3.6 µM, ANS 17 µM. Excitation wavelength 370 nm, slit 1, without 
polarization. Graphic 1 show the results with the constant spectra of polymer nanoparticles subtracted from the 
diminished spectra of the protein. Graphic 2 show the results without the constant spectra of polymer 
nanoparticles subtracted from the diminished spectra of the protein. 
Signal of PP subtracted 
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Given only the graphics with the constant signal of polymer nanoparticles subtracted, it was 
possible to observe that the intensity of BSA-polymer nanoparticle constructs were always 
weaker than the intensity with only BSA protein. This fact indicated that ANS resides in a 
more polar environment when polymer nanoparticles were present in the sample. The main 
difference was at pH 7.4, followed by pH 9, which matches what was reported before. The 
maximum emission peaks almost did not change and it was possible only see a slight 
increase at pH 7.4 from 470 nm to 480 nm. Concerning the results of two types of 
nanoparticles size, no important variations were appreciated and the conduct was similar.  
However, it would not be entirely correct to compare only the results of the samples with the 
signal of the particles removed. ANS fluorescence is affected for BSA and polymer 
nanoparticles at the same time. For this reason, now it makes reference to the other two 
graphics (graphic 2 of Figure 5.17 and 5.18) with no polymer nanoparticles signal 
subtracted. Spectra at pH 3.8 almost did not change, spectra at pH 7.4 increase its intensity 
in relation to the sample of BSA and at pH 9 spectra decrease. Finally in all cases the 
wavelength of maximum emission shifted slightly to lower value, from 470 to 465 
approximately. Although it might seem meaningless it is not the case. The decrease in the 
wavelength could be explained because ANS-BSA were closer packed on the particle 
surface and thus more protected from solvent. Referring to the signal with and without 
polymer nanoparticles interference, more differences were at pH 7.4 which means that the 
total amount of ANS attached on the polymer nanoparticles was higher than the other two in 
this value. At pH 3.8 and 9 ANS was not affected for the polymer nanoparticles and there 
are not so many changes before and after to remove polymer nanoparticles signal. Thus it 
is possible to conclude the same has been said so far, but should it be clarify that at pH 7.4 
spectra is interfered by polymer nanoparticles. 
 
Herein, it seems that the most favourable condition for partial unfolding of BSA was at pH 
7.4. In the study reported by Yasudas et al. [50] the immobilized amount of BSA on anionic 
polymer nanoparticles at pH 3.8 was highest of all tested in that study and concluded that 
this could be explained either by dimer formation onto epoxy-coated polymer nanoparticles 
below the pI of BSA, or by optimized packing of the protein layer under these conditions. 
However, at or close to complete surface coverage, the protein was tightly packed and more 
likely to retain its native structure, whereas low fractional surface coverage in that case 
enabled multipoint conjugation with available epoxy groups. This might explain the results 
which demonstrate that highest degree of conformational changes were at neutral and high 
pH instead at low pH. 
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5.3.4. Intrinsic and extrinsic fluorescence of BSA-polymer nanoparticle 
constructs. Surface group comparison. 
Two different types of polymer nanoparticles with the same size was used, one with epoxy 
groups and one without epoxy groups, and the fluorescence spectra of BSA-polymer 
nanoparticle were compared. The polymer nanoparticle with epoxy groups was the same as 
the previous point. It is expected electrostatic attachment and covalent binding with lysine, 
histidine and arginine residues on the polymer nanoparticles with epoxy groups and just 
electrostatic attachment in polymer nanoparticles without epoxy groups. Table 5.8 shows all 
the samples and its composition.  
Table 5.8. BSA-polymer nanoparticle constructs. Polymer nanoparticles 3.75 mg/ml, BSA 3.6 µM. Surface group 
comparison.   
Sample pH Polymer nanoparticles type 
7 3.8 Polymer nanoprticles 227 nm without epoxy groups 
8 7.4 Polymer nanoprticles 227 nm without epoxy groups 
9 9 Polymer nanoprticles 227 nm without epoxy groups 
Each sample was divided in two, then one half was mixed with ANS 17 µM as in the 
previous section. Finally fluorescence emission spectroscopy was completed and the results 
compared with the spectra of BSA. Polymer nanoparticles fluorescence spectra were also 
remove from the signal. Figure 5.19 shows the results of intrinsic fluorescence and Figure 
5.20 the result of extrinsic fluorescence. 
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Figure.  5.19. Intrinsic fluorescence emission spectra of BSA in the presence and absence of polymer 
nanoparticles at different pH. The concentrations used were: polymer nanoparticles 227 nm without epoxy 
groups 3.75 mg/ml (if it corresponds), BSA 3.6 µM, ANS 0 µM. Excitation wavelength 295 nm, slit 5, polarization 
90º. Constant spectra of polymer nanoparticles were subtracted from the diminished spectra of the protein.  
The results of polymer nanoparticles without epoxy groups were in accordance with the 
others; all samples with polymer nanoparticles had less intensity, higher wavelength of 
maximum emission and it was difficult to find any meaning at pH 3.8. However, some 
important differences could be observed. The intensity of samples containing polymer 
nanoparticles without epoxy groups was a bit higher than in the other samples and this is an 
evidently indication which verify that Trp residues were buried for more hydrophobic 
environment and BSA protein less unfolded. The red shift of the maximum emission peak 
was not as pronounced as in particles with epoxy groups, 380 nm at pH 7.4 and 375 nm at 
pH 9 instead of 385 nm as the other cases. Thus it could be possible that polymer 
nanoparticles without epoxy groups, independently of the total amount of attached BSA, 
induced less conformational changes in the protein. 
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Figure. 5.20. Extrinsic ANS fluorescence emission spectra of BSA in the presence and absence of polymer 
nanoparticles at different pH. The concentrations used were: polymer nanoparticles 227 nm without epoxy 
groups 3.75 mg/ml (if it corresponds), BSA 3.6 µM, ANS 17 µM. Excitation wavelength 370 nm, slit 1, without 
polarization. Graphic 1 show the results with the constant spectra of polymer nanoparticles subtracted from the 
diminished spectra of the protein. Graphic 2 show the results without the constant spectra of polymer 
nanoparticles subtracted from the diminished spectra of the protein. 
Signal of PP subtracted 
Protein-nanoparticle constructs for intracellular delivery  p. 69 
 
Extrinsic fluorescence spectra of polymer nanoparticles without epoxy groups differed 
considerably from the values of polymer nanoparticles with epoxy groups. Given only the 
graphics with the constant spectra of polymer nanoparticles subtracted (figure 6.16 graphic 
1 and 3), the intensity of BSA-polymer nanoparticle constructs remained weaker than the 
intensity with only BSA protein. However, the sequence pH 7.4, pH 9 and pH 3.8 respects to 
the importance of changes was not followed. In this case interaction between BSA and 
polymer nanoparticles was purely electrostatic and this is the reason for the results. At pH 9 
it was hardly any changes in emission intensity because the surface charge for both BSA 
and polymer nanoparticles was negative, and electro static repulsion occurred, while the 
most important variation was at pH 3.8 where proteins had positively surface charge and 
proteins negatively charge. There was no change in the emission maxima and only at pH 
7.4 was it possible to identify some shifts, from 470 nm of BSA to 475 nm of BSA-polymer 
nanoparticle. For this reason it was possible that, although the immobilized amount of BSA 
on anionic polymer nanoparticles at pH 3.8 was highest, the protein was tightly packed and 
more likely to retain its native structure. The intensity and wavelength changes were not as 
pronounced as for polymer nanoparticles with epoxy groups, which means that covalent 
bonding induced more conformational changes. Compared to the other two graphics (Figure 
7.16, graphics 2 and 4), which the baseline was extracted, there was no big difference in 
the emission from ANS at pH 9 whether the PP-baseline was subtracted or not. On the 
other hand, at pH 7.4 and pH 3.8 there was a big discrepancy in the intensity before and 
after the baseline extraction. Intensity increases a lot and the wavelength decrease 
slightly if baseline is not removed; these events could be related to the binding of ANS to 
the polymer nanoparticles instead of BSA, maybe because sulfonate group of ANS was 
strong attracted by positively surface charges of the nanoparticles. 
Herein, it seems that polymer nanoparticle without epoxy groups induced less 
conformational changes to BSA protein. The most favourable conditions could be at pH 7.4 
(as in the previous cases) while at pH 9 electrostatic repulsion was too strong and at pH 3.8 
electrostatic binding was tightly and favourable to retain protein native structure. Thus, as a 
finally conclusions it appears that big polymer nanoparticles with epoxy groups are the best 
option and pH 7.4 the best conditions. 
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5.4. Unfolding studies of immobilized BSA using urea in 
combination with ANS 
The use of urea as denaturation agent induces to protein unfolding [116]. Thus by 
increasing the concentration of urea in a sample containing BSA it is possible to study the 
different intermediate state that following the complete denaturation of the protein. The 
present section aims to elucidate the conformational changes experimented by BSA-
polymer nanoparticle constructs caused by varying denaturation conditions.  Structural 
changes were detected by fluorescence spectroscopy using ANS as an external probe. 
5.4.1. Extrinsic fluorescence of BSA-polymer nanoparticle constructs in urea 
solution.  
Polymer nanoparticles 227 nm and 153 nm with epoxy groups were used in the experiment. 
Figure 5.21 and 5.22 show the fluorescence emission spectra of BSA with polymer 
nanoparticles 227 nm and polymer nanoparticles 153 nm in different urea concentration and 
pH. Finally maximum intensity as a function of urea concentration in each case was plotted 
in Figure 5.23.  
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Figure 5.21. Extrinsic ANS fluorescence emission spectra of BSA in the presence of polymer nanoparticles 227 
nm with epoxy groups and different urea concentrations. The concentrations used were: polymer nanoparticles 
3.75 mg/ml, BSA 3.6 µM, ANS 17 µM, urea 0-8 M. Excitation wavelength 370 nm, slit 1, without polarization. 
Graphic 1 shows the results at pH 3.8. Graphic 2 shows the results at pH 7.4. Graphic 3 shows the results at pH 
9. 
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Figure 5.22. Extrinsic ANS fluorescence emission spectra of BSA in the presence of polymer nanoparticles 153 
nm with epoxy groups and different urea concentrations. The concentrations used were: polymer nanoparticles 
3.75 mg/ml, BSA 3.6 µM, ANS 17 µM, urea 0-8 M. Excitation wavelength 370 nm, slit 1, without polarization. 
Graphic 1 shows the results at pH 3.8. Graphic 2 shows the results at pH 7.4. Graphic 3 shows the results at pH 
9. 
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Figure 5.23. Changes in the ANS fluorescence intensity caused by increasing urea concentration. The 
concentrations used were: polymer nanoparticles 3.75 mg/ml, BSA 3.6 µM, ANS 17 µM, urea 0-8 M. Excitation 
wavelength 370 nm, slit 1, without polarization. Graphic 1 shows the results of polymer nanoparticles 227 nm 
with epoxy groups. Graphic 2 shows the results of polymer nanoparticles 153 nm with epoxy groups. 
The intensity of emission decreased by increasing the urea concentration due to ANS got 
more access to the solvent.  Regarding the results of BSA-polymer nanoparticle 227 nm 
and BSA-polymer nanoparticles 153 nm with epoxy groups there were no appreciated 
difference between them. Moreover it was not possible to identify any transition between 
conformations in the BSA. Thus it could be possible that urea affected the sample in such a 
way that the results did not represent the conformational changes of BSA. It would be 
recommended to find another procedure for the unfolding studies of the protein.    
5.5. Studies of immobilized BSA by isothermal titration 
calorimetey 
The adsorption of BSA on the surface of polymer nanoparticles was studied by isothermal 
tritation calorimetry. As from the other sections it was deduced that at pH 7.4 the conditions 
were favourable for the attached followed conformational isomerisation of BSA, the 
experiments were carried out at this pH. Polymer nanoparticles 227 nm with epoxy groups 
were used as a model template. However since the use of this technique for the present 
purpose resides at the beginning, enthalpy, stoichiometry and equilibrium constant could not 
be deduced and it is necessary to do a more exhaustive experimentation for this purpose.  
Thus in the present section the results are treated qualitatively to identify the most relevant 
thermodynamics aspects of the adsorption process of BSA. 
The results are shown in a graphic form where the heat rate [µW] released or absorbed 
from the reaction were plotted as a function of time [s] during the titrations. If the reaction is 
exothermic the heat rate should increase positively after each titration and if the reaction is 
endothermic the heat rate should increases negatively after each titration. During the first 
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titrations the absolute value of heat rate should be high since all BSA titrated reacts with the 
polymer nanoparticles. At the last titrations the absolute value of heat rate should be low 
since the solution has reached the equilibrium and there is no reaction. Figure 5.24 show 
the titration process at pH 7.4 of BSA 36 µM in a sample cell of polymer nanoparticles 227 
nm with epoxy groups at different concentrations (3.75 mg/ml, 7.5 mg/ml and 11.25 mg/ml). 
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Figure 5.24. Syringe: 100 ul of BSA 36 µM adjusted at pH 7.4. Sample cell: Polymer nanoparticles 227 nm with 
epoxy groups adjusted at pH 7.4. Increasing concentration of polymer particles in the sample cell: 3.75 mg/ml 
(graphic 1), 7.5 mg/ml (graphic 2) and 11.25 mg/ml (graphic 3). Experiment consisting in 25 titrations (19 
titrations graphic 3) of 4 ul of BSA every 500 s. The first titration was at 120 s and the last measurement 120 s 
after the last titration.  
According to graphic 1 of Figure 5.24 it seemed that some kind of reaction existed due to 
the fact that at the first titrations an exothermic peak could be observed. After four-six 
titrations this peak disappeared which means that all polymer particles 227 nm with epoxy 
groups had reacted. The adsorption process was exothermic but it was also possible to see 
an endothermic signal which could be derived form the mixture of the two samples. By 
increasing the concentration of polymer particles (graphics 2 and 3 of Figure 5.24) it would 
be expected to reach the equilibrium of the reaction after 10 or more titrations and see more 
exothermic peaks but it was not the case. After 4 titrations the reaction finished and it was 
only possible to see the endothermic peak from the mixture of the samples. However when 
the concentration of polymer particles was high (11.25 mg/ml) an exothermic behaviour was 
detected after the endothermic peak. Perhaps it was caused by a slow subprocess protein 
adsorption. Finally, although the graphics show a reaction process at the beginning of the 
titration, for the moment it is necessary with a more accurate experimental procedure to 
reach any conclusions. The results are not well defined enough to calculate the 
thermodynamic parameters of the adsorption.      
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Conclusions 
In the present project a set of experiments have been performed in order to develop and 
evaluate the use of polymer nanoparticles as a stable support for BSA immobilization.  
Negatively charged monodisperse polymer nanoparticles functionalized with epoxy groups 
were synthesized by soap free emulsion polymerization. The samples showed a narrow 
polydispersity with the diameter of the particles inversely proportional to the stirring speed 
during the polymerization process. This fact indicated the validity of the method for the 
synthesizing of nanosized polymer particles and the possibility to obtain different diameters. 
The elimination of the epoxy groups did not resulted in physical alteration of the sample. 
Thus it was possible to functionalize the polymer nanoparticles with epoxy groups or remove 
them for purely electrostatic interaction. Polymer nanoparticles resided stable in the entire 
range of pH. 
Immobilization of BSA was found to induce conformational changes in the protein. From 
zeta potential measurements, pI of BSA shifted to lower values when it was attached on the 
surface of the polymer nanoparticles and these shifts depended on the type used. By 
comparing the fluorescence emission spectra of different BSA-polymer nanoparticle 
constructs, it was determined that BSA immobilization and degree of unfolding was strongly 
affected by pH and surface groups. The results suggested that polymer nanoparticles with 
epoxy groups offered covalent binding and induced larger BSA conformational isomerisation 
than polymer nanoparticles without epoxy groups. These conformational alterations 
occurred to the largest degree at pH 7.4 since it was possible that at these conditions a high 
number of amino groups from BSA blended with epoxy groups of the nanoparticles. At pH 
3.8 electrostatic attraction increased the number of adsorbed protein but no conformational 
changes were appreciated while at pH 9 adsorbed protein and induced conformational 
changes were in an intermediate level. Finally, there were no considerable discrepancies 
between polymer nanoparticles with different diameters.  
Hence, the use of polymer nanoparticles as a stable support for BSA immobilization can be 
a good alternative in the monitoring of this protein. Nevertheless it is necessary to do an 
exhaustive research to understand the underlying of BSA adsorption and the conformational 
changes that are induced, as well as the total amount of attached protein on the polymer 
nanoparticles. ITC measurements could be a good choice for the study but at this moment it 
is necessary to realise further experiments.  
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Unit: Ugelstad Laboratory                   Date: 14/02/11 
  
Participants in the identification process (including their function): Jordi Piella Bagaria (Designer) 
 
Short description of the main activity/main process: Experimentation with chemical reagents, laboratory scale. 
 
(Id.) Activity/process Responsible 
person 
Laws, regulations etc. Existing 
documentation 
Existing safety 
measures 
Comment 
(1) Divinylbenzene 
technical grade, 80% 
(handling and storage) 
 
Jordi Piella 
Bagaria 
Regulation (EC) No 
1272/2008 [EU-GHS/CLP]. 
EU Directives 67/548/EEC 
or 1999/45/EC. 
Regulation (EC) No 
1272/2008 [CLP]. 
European Directive 
67/548/EEC as amended. 
Material safte 
data sheet. 
HSE handbook. 
Lab handbook. 
Operation 
manual. 
Checklist. 
Protective equipment and 
emergency procedures. 
Normal measures for 
preventive fire protection. 
Conditions for safe 
storage. 
Use equipment for eye 
protection tested and approved 
under appropriate government 
standards such as NIOSH (US) 
or EN 166(EU). The selected 
protective gloves have to satisfy 
the specifications of EU 
Directive 89/686/EEC and the 
standard EN 374 derived from it. 
For nuisance exposures use 
type OV/AG (US) or type ABEK 
(EU EN 14387) respirator 
cartridges. Use respirators and 
components tested and 
approved under appropriate 
government standards such as 
NIOSH (US) or CEN (EU). 
NTNU Prepared by Number Date 
HSE section HMSRV-26/01 01.12.2006 
 Approved by Page Replaces 
HSE 
Appendix A: Hazardous activity identification process 
The Rector 2 out of 4 15.12.2003  
 
 
(2) Glycidyl methacrylate, 
97% (handling and 
storage) 
 
 
Jordi Piella 
Bagaria 
Regulation (EC) No 
1272/2008 [EU-GHS/CLP]. 
EU Directives 67/548/EEC 
or 1999/45/EC. 
Regulation (EC) No 
1272/2008 [CLP]. 
European Directive 
67/548/EEC as amended. 
Material safte 
data sheet. 
HSE handbook. 
Lab handbook. 
Operation 
manual. 
Checklist. 
Protective equipment and 
emergency procedures. 
Normal measures for 
preventive fire protection. 
Conditions for safe 
storage. 
Face shield and safety glasses 
Use equipment for eye 
protection tested and approved 
under appropriate government 
standards such as NIOSH (US) 
or EN 166(EU). The selected 
protective gloves have to satisfy 
the specifications of EU 
Directive 89/686/EEC and the 
standard EN 374 derived from it. 
Where risk assessment shows 
air-purifying respirators are 
appropriate use a full-face 
respirator with multi-purpose 
combination (US) or type ABEK 
(EN 14387) respirator cartridges 
as a backup to engineering 
controls. If the respirator is the 
sole means of protection, use a 
full-face supplied air respirator. 
Use respirators and components 
tested and approved under 
appropriate government 
standards such as NIOSH (US) 
or CEN (EU). 
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(3) Styrene RegeantPlus, 
99%>= (handling and 
storage) 
 
Jordi Piella 
Bagaria 
Regulation (EC) No 
1272/2008 [EU-GHS/CLP]. 
EU Directives 67/548/EEC 
or 1999/45/EC. 
Regulation (EC) No 
1272/2008 [CLP]. 
European Directive 
67/548/EEC as amended. 
Material safte 
data sheet. 
HSE handbook. 
Lab handbook. 
Operation 
manual. 
Checklist. 
Protective equipment and 
emergency procedures. 
Normal measures for 
preventive fire protection. 
Conditions for safe 
storage. 
Face shield and safety 
glasses.Use equipment for eye 
protection tested and approved 
under appropriate government 
standards such as NIOSH (US) 
or EN 166(EU). The selected 
protective gloves have to satisfy 
the specifications of EU 
Directive 89/686/EEC and the 
standard EN 374 derived from it. 
Where risk assessment shows 
air-purifying respirators are 
appropriate use a full-face 
respirator with multi-purpose 
combination (US) or type ABEK 
(EN 14387) respirator cartridges 
as a backup to engineering 
controls. If the respirator is the 
sole means of protection, use a 
full-face supplied air respirator. 
Use respirators and components 
tested and approved under 
appropriate government 
standards such as NIOSH (US) 
or CEN (EU). 
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(4) Ammonium persulfat 
(handling and storage) 
 
Jordi Piella 
Bagaria 
Regulation (EC) 
No1272/2008 
European Directive 
67/548/EEC as amended 
Material safte 
data sheet. 
HSE handbook. 
Lab handbook. 
Operation 
manual. 
Checklist. 
Protective equipment and 
emergency procedures. 
Normal measures for 
preventive fire protection. 
Conditions for safe 
storage. 
Where risk assessment shows 
air-purifying respirators are 
appropriate use a full-face 
particle respirator type N100 
(US) or type P3 (EN 143) 
respirator cartridges as a 
backup to engineering controls. 
If the respirator is the sole 
means of protection, use a full-
face supplied air respirator. Use 
respirators and components 
tested and approved under 
appropriate government 
standards such as NIOSH (US) 
or CEN (EU). The selected 
protective gloves have to satisfy 
the specifications of EU 
Directive 89/686/EEC and the 
standard EN 374 derived from it. 
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Unit: Ugelstad Laboratory              Date:  14/02/11 
Line manager: Wilhelm Robert Glomm 
Participants in the risk assessment (including their function): Jordi Piella Bagaria (Designer) 
 
Likelihood: Consequence: (Id.) Activity from the 
identification process 
form 
Potential 
undesirable 
incident/strain  
Likelihood 
(1-4) 
Human 
(1-4) 
Environm
ent  
(1-4) 
Economy/ 
materiel 
(1-4) 
Risk 
value 
Comments/status 
Suggested measures 
(1) Divinylbenzene 
technical grade, 80% 
(handling and storage) 
Accidental release 1 2 1 1 2+1+1 Preventive: Store in cool place. Keep 
container tightly closed in a dry and well-
ventilated place. Containers which are 
opened must be carefully resealed and 
kept upright to prevent leakage.  
Corrective: Avoid breathing vapours, 
mist or gas. Use personal protective 
equipment: Eye/face protection, skin 
protection, body protection, respiratory 
protection. Do not let product enter 
drains. Keep in suitable, closed 
containers for disposal. 
(1) Divinylbenzene 
technical grade, 80% 
(handling and storage) 
Fire  1 2 1 2 2+1+2 Corrective: Use water spray, alcohol-
resistant foam, dry chemical or carbon 
dioxide as extinguishing media.  
(2) Glycidyl methacrylate, 
97% (handling and 
storage) 
Accidental release 1 2 1 1 2+1+1 Preventive: Store in cool place. Keep 
container tightly closed in a dry and well-
ventilated place. Containers which are 
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opened must be carefully resealed and 
kept upright to prevent leakage.  Avoid 
contact with skin and eyes. Avoid 
inhalation of vapour or mist.  
Corrective: Avoid breathing vapours, 
mist or gas. Ensure adequate ventilation. 
Remove all sources of ignition. Evacuate 
personnel to safe areas. Beware of 
vapours accumulating to form explosive 
concentrations. Vapours can accumulate 
in low areas. Keep away from sources of 
ignition - No smoking. Take measures to 
prevent the build up of electrostatic 
charge. Use personal protective 
equipment: Eye/face protection, skin 
protection, body protection, respiratory 
protection. Prevent further leakage or 
spillage if safe to do so. Do not let 
product enter drains. Contain spillage, 
and then collect with an electrically 
protected vacuum cleaner or by wet-
brushing and place in container for 
disposal according to local regulations. 
Keep in suitable, closed containers for 
disposal. 
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(2) Glycidyl methacrylate, 
97% (handling and 
storage) 
Fire  1 2 1 2 2+1+1 Corrective: Use water spray, alcohol-
resistant foam, dry chemical or carbon 
dioxide as extinguishing media.  
(3) Styrene RegeantPlus, 
99%>= (handling and 
storage) 
Accidental release 1 2 1 1 2+1+1 Preventive: Store in cool place. Keep 
container tightly closed in a dry and well-
ventilated place. Containers which are 
opened must be carefully resealed and 
kept upright to prevent leakage.  Handle 
in accordance with good industrial 
hygiene and safety practice. Wash hands 
before breaks and at the end of workday. 
Corrective: Avoid contact with skin and 
eyes. Avoid inhalation of vapour or mist. 
Keep away from sources of ignition - No 
smoking. Take measures to prevent the 
build up of electrostatic charge. Use 
personal protective equipment: Eye/face 
protection, skin protection, body 
protection, respiratory protection. Use 
personal protective equipment. Avoid 
breathing vapours, mist or gas. Ensure 
adequate ventilation. Remove all sources 
of ignition. Beware of vapours 
accumulating to form explosive 
concentrations. Vapours can accumulate 
in low areas. Prevent further leakage or 
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spillage if safe to do so. Do not let 
product enter drains. Discharge into the 
environment must be avoided. Contain 
spillage, and then collect with an 
electrically protected vacuum cleaner or 
by wet-brushing and place in container 
for disposal according to local 
regulations. 
(3) Styrene, 
RegeantPlus, 99%>= 
(handling and storage) 
Fire  1 2 1 2 2+1+2 Corrective: Use water spray, alcohol-
resistant foam, dry chemical or carbon 
dioxide as extinguishing media. Use 
water spray to cool unopened containers. 
(4) Ammonium persulfat 
(handling and storage) 
Accidental release 1 2 1 1 2+1+1 Preventive: Store in cool place. Keep 
container tightly closed in a dry and well-
ventilated place.  
Corrective: Avoid contact with skin and 
eyes. Avoid formation of dust and 
aerosols. Provide appropriate exhaust 
ventilation at places where dust is 
formed. Keep away from sources of 
ignition - No smoking. Keep away from 
combustible material. Moisture sensitive.    
Use personal protective equipment. 
Avoid dust formation. Avoid breathing 
dust. Ensure adequate ventilation. 
Evacuate personnel to safe areas. Do 
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not let product enter drains. Pick up and 
arrange disposal without creating dust. 
Keep in suitable, closed containers for 
disposal. 
(4) Ammonium persulfate 
98+%, A.C.S. reagent 
(handling and storage) 
Fire  1 2 1 2 2+1+2 Corrective: Use water spray, alcohol-
resistant foam, dry chemical or carbon 
dioxide as extinguishing media. May 
intensify fire; oxidiser. Use water spray to 
cool unopened containers. 
 
Likelihood, e.g.: Consequence, e.g.: Risk value (each one to be estimated separately): 
1. Minimal 
2. Low 
3. High 
4. Very high 
1. Relatively safe  
2. Dangerous  
3. Critical  
4. Very critical 
Human = Likelihood  x Human Consequence  
Environmental = Likelihood  x Environmental consequence 
Financial/material = Likelihood  x Consequence for Economy/materiel 
 
 
 
 
 
 
 
 
 
 
 
 
NTNU Prepared by Number Date 
HSE section HMSRV-26/03 01.12.2006 
 Approved by Page Replaces 
HSE/KS 
Appendix B: Risk assessment 
The Rector 6 out of 7 15.12.2003  
 
 
Potential undesirable incident/strain 
Identify possible incidents and conditions that may lead to situations that pose a hazard to people, the environment and any materiel/equipment 
involved. 
 
Criteria for the assessment of likelihood and consequence in relation to fieldwork 
Each activity is assessed according to a worst-case scenario. Likelihood and consequence are to be assessed separately for each potential 
undesirable incident. Before starting on the quantification, the participants should agree what they understand by the assessment criteria: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The likelihood of something 
going wrong is to be 
assessed according to the 
following criteria: 
1 Minimal 
 Once every 10 years 
or less 
 
2 Low 
 Once a year 
 
3 High 
 Once a month 
 
4 Very high 
Once a week or more 
often 
Human consequence is to be assessed 
according to the following criteria: 
1 Relatively safe  
 Injury that does not involve absence 
from work; insignificant health risk  
 
2 Dangerous 
 Injury that involves absence from 
work; may produce acute sickness  
 
3 Critical 
 Permanent injury; may produce 
serious health damage/sickness 
 
4 Very critical 
 Injury that may produce fatality/ies 
 
Environmental consequences are assessed 
according to the following criteria: 
1 Relatively safe    
 Insignificant impact on the environment 
 
2 Dangerous 
 Possibility of undesirable long term effects; 
some cleanup is to be expected 
 
3 Critical 
Undesirable long term effects; cleanup to be 
expected  
 
4 Very critical 
Damaging to living organisms; irreversible 
impact on the environment; cleanup must be 
undertaken 
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The unit makes its own decision as to whether opting to fill in or not consequences for economy/materiel, for example if the unit is going to use 
particularly valuable equipment. It is up to the individual unit to choose the assessment criteria for this column. 
 
Risk = Likelihood x Consequence  
 
Please calculate the risk value for “Human”, “Environment” and, if chosen, “Economy/materiel”, separately. For activities with a risk value of 16 
or 12, or a single value of 4, safety measures (designed to both reduce the likelihood and to limit the consequences) must be documented with 
descriptions of measures and allocation of responsibility.  
 
About the column “Comments/status, suggested preventative and corrective measures”: 
Measures can impact on both likelihood and consequences. Prioritise measures that can prevent the incident from occurring; in other words, 
likelihood-reducing measures are to be prioritised above greater emergency preparedness, i.e. consequence-reducing measures.  
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Unit: Ugelstad Laboratory__________________________________________________________________________________ 
 
What Measure Unit 
responsible 
Priority Cost Current status 
(1) Divinylbenzene technical grade, 80% (handling and 
storage) 
 
Safe storage of the 
substance. 
Availability of protective 
clothing.  
Jordi Piella 
Bagaria 
Human  OK 
(2) Glycidyl methacrylate, 97% (handling and storage) 
 
 
Safe storage of the 
substance. 
Availability of protective 
clothing. 
Jordi Piella 
Bagaria 
Human  Ok 
(3) Styrene RegeantPlus, 99%>= (handling and 
storage) 
 
 
Safe storage of the 
substance. 
Availability of protective 
clothing. 
Jordi Piella 
Bagaria 
Human  OK 
(4) Ammonium persulfat (handling and storage) 
 
 
Safe storage of the 
substance. 
Availability of protective 
clothing. 
Jordi Piella 
Bagaria 
Human  OK 
 
Date: 15/02/11__________________  Line manager: Wilhelm Robert Glomm _________________________________________ 
 
